Sentence,class,file
"2: 87- 93, June 2014 http://dx.doi.org/10.3342/ceo.2014.7.2.87 Original Article INTRODUCTION Tinnitus is generally defined as a perception of sound in the ab - sence of an external acoustic stimulus.",Non-OADS,/arxiv_data1/oa_pdf/09/7f/ceo-7-87.PMC4050093.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Advantages of Binaural Amplification to Acceptable  Noise Level of Directional Hearing Aid Users Ja-Hee Kim1,2·Jae Hee Lee2·Ho-Ki Lee3 1Department of Otorhinolaryngology-Head and Neck Surgery, Hallym University College of Medicine, Anyang; 2Department of Audiology,  Hallym University of Graduate Studies, Seoul; 3Soree Ear Clinic, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/ea/ec/ceo-7-94.PMC4050094.pdf
"2: 94- 101, June 2014 http://dx.doi.org/10.3342/ceo.2014.7.2.94 Original Article INTRODUCTION A major problem for most hearing aid users is understanding  speech in background noise.",Non-OADS,/arxiv_data1/oa_pdf/ea/ec/ceo-7-94.PMC4050094.pdf
Nat Rev Cancer 2005; 5:615- 25; PMID:16034368 ; http://dx.doi.org/10.1038/ nrc1669 2.,Non-OADS,/arxiv_data1/oa_pdf/a4/9d/cc-13-1359.PMC4050126.pdf
Proc Natl Acad Sci U S A 2009;  106:13493-8;  PMID:19651608 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/9d/cc-13-1359.PMC4050126.pdf
PLoS One 2011; 6:e17876; PMID:21437249 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/a4/9d/cc-13-1359.PMC4050126.pdf
Ann Oncol 2011; 22:98-103;  PMID:20610479 ; http://dx.doi.org/10.1093/ annonc/mdq325 5.,Non-OADS,/arxiv_data1/oa_pdf/a4/9d/cc-13-1359.PMC4050126.pdf
Clin Lung Cancer 2009; 10:371-4; PMID:19808198 ; http://dx.doi.org/10.3816/ CLC.2009.n.052 6.,Non-OADS,/arxiv_data1/oa_pdf/a4/9d/cc-13-1359.PMC4050126.pdf
Mol Oncol 2013; 7:859-69;  PMID:23890733 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/9d/cc-13-1359.PMC4050126.pdf
"molonc.2013.07.005 *Correspondence to: Otavia L Caballero; Email: ocaball1@jhmi.edu Submitted: 02/14/2014; Accepted: 03/04/2014; Published Online: 04/03/2014http://dx.doi.org/10.4161/cc.28747Comment on: Caballero OL, et al.",Non-OADS,/arxiv_data1/oa_pdf/a4/9d/cc-13-1359.PMC4050126.pdf
"Their  *Correspondence to: Yoel Kloog; Email: kloog@post.tau.ac.il Submitted: 03/12/2014; Accepted: 03/16/2014; Published Online: 04/03/2014http://dx.doi.org/10.4161/cc.28748Comment on: Rak R, et al.",Non-OADS,/arxiv_data1/oa_pdf/ee/31/cc-13-1360.PMC4050127.pdf
Clin Cancer Res 2006; 12:5533-42; PMID:17000690 ; http://dx.doi.org/10.1158/1078- 0432.CCR-06-0792 3.,Non-OADS,/arxiv_data1/oa_pdf/ee/31/cc-13-1360.PMC4050127.pdf
Manetti F. Med Res Rev 2012; 32:968-98; PMID:22886629 ; http://dx.doi.org/10.1002/ med.20230 4.,Non-OADS,/arxiv_data1/oa_pdf/ee/31/cc-13-1360.PMC4050127.pdf
Cell Res 2011; 21:666-82;  PMID:21079653 ; http://dx.doi.org/10.1038/ cr.2010.154 5.,OADS,/arxiv_data1/oa_pdf/ee/31/cc-13-1360.PMC4050127.pdf
J Cell Sci 2012; 125:1204-16; PMID:22492986 ; http://dx.doi.org/10.1242/ jcs.092304 6.,OADS,/arxiv_data1/oa_pdf/ee/31/cc-13-1360.PMC4050127.pdf
PLoS One 2012; 7:e47283;  PMID:23082153 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ee/31/cc-13-1360.PMC4050127.pdf
"This work also illustrates that we are still far from a detailed understanding of Mediator functions and of functional  *Correspondence to: Email: julie.soutourina@cea.fr Submitted: 02/17/2014; Accepted: 03/05/2014; Published Online: 04/03/2014http://dx.doi.org/10.4161/cc.28749Comment on: Eyboulet F, et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/0e/cc-13-1362.PMC4050128.pdf
"Genes Dev 2013; 27:2549-62; PMID:24298055; http://dx.doi.org/10.1101/gad.225813.113A novel link of Mediator with DNA repair Julie s outourina* and Michel Werner CEa; iBitec-s; FrE3377; Gif-sur- yvette, France; CN rs; FrE3377; Gif-sur- yvette, France; u niv Paris- sud; F rE3377; Gif-sur- yvette, France",Non-OADS,/arxiv_data1/oa_pdf/2b/0e/cc-13-1362.PMC4050128.pdf
Trends Biochem Sci 2005; 30:235 -9;  PMID:15896740 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/0e/cc-13-1362.PMC4050128.pdf
Mol Cell 2008; 31:337-46;  PMID:18691966 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/0e/cc-13-1362.PMC4050128.pdf
Science 2011; 331:1451-4; PMID :21415355 ; http://dx.doi.org/10.1126/ science.1200188 4.,Non-OADS,/arxiv_data1/oa_pdf/2b/0e/cc-13-1362.PMC4050128.pdf
Genes Dev 2013; 27:2549-62;  PMID:24298055 ; http://dx.doi.org/10.1101/ gad.225813.113 5.,OADS,/arxiv_data1/oa_pdf/2b/0e/cc-13-1362.PMC4050128.pdf
DNA Repair (Amst) 2011; 10:743-50; PMID:21622031 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/0e/cc-13-1362.PMC4050128.pdf
Trends Biochem Sci 2007; 32:165- 71; PMID:17349792 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/0e/cc-13-1362.PMC4050128.pdf
Mol Cell 2010; 38:54-66; PMID:20385089 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/0e/cc-13-1362.PMC4050128.pdf
Mol Cell 2012; 47:622-32;  PMID:22771116 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/0e/cc-13-1362.PMC4050128.pdf
"7  Altogether, these data converge to the  *Correspondence to: Domenico Maiorano; Email: domenico.maiorano@igh.cnrs.fr Submitted: 01/30/2014; Accepted: 02/05/2014; Published Online: 04/03/2014http://dx.doi.org/10.4161/cc.28750Comment on: van der Laan S, et al.",Non-OADS,/arxiv_data1/oa_pdf/25/8c/cc-13-1364.PMC4050129.pdf
"Mol Cell 2013; 52:366-79; PMID:24207026; http://dx.doi.org/10.1016/j.molcel.2013.10.003Post-translational modifications in embryonic   cell cycle siem Van der Laan and d omenico Maiorano* Genome s urveillance and s tability Laboratory; d epartment Molecular Bases of Human d iseases; CN rs-uPr1142; i nstitute of Human Genetics; Montpellier, France",OADS,/arxiv_data1/oa_pdf/25/8c/cc-13-1364.PMC4050129.pdf
Curr Biol 2011; 21:45-52;  PMID:21167714; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/8c/cc-13-1364.PMC4050129.pdf
Stem Cells 2012; 30:1097-108;  PMID:22415928; http://dx.doi.org/10.1002/ stem.1078 3.,Non-OADS,/arxiv_data1/oa_pdf/25/8c/cc-13-1364.PMC4050129.pdf
Cell 2013; 155:135-47;  PMID:24074866; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/8c/cc-13-1364.PMC4050129.pdf
Nature 2009; 462:358-62; PMID:19924215; http://dx.doi.org/10.1038/ nature08575 5.,Non-OADS,/arxiv_data1/oa_pdf/25/8c/cc-13-1364.PMC4050129.pdf
Cell Stem Cell 2012; 11:783- 98; PMID:23103054; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/8c/cc-13-1364.PMC4050129.pdf
Mol Cell 2013; 52:366-79;  PMID:24207026; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/8c/cc-13-1364.PMC4050129.pdf
Curr Biol 2013; 23:118-26; PMID:23290551; http://dx.doi.org/10.1016/j.cub.2012.11.036Figure 1.  schematic representation of developmental transitions mediated by protein post-trans - lational modifications (P tMs).,OADS,/arxiv_data1/oa_pdf/25/8c/cc-13-1364.PMC4050129.pdf
"The current and further understandings of the N-end  *Correspondence to: Cheol-Sang Hwang; Email: cshwang@postech.ac.kr Submitted: 02/11/2014; Accepted: 03/05/2014; Published Online: 04/03/2014http://dx.doi.org/10.4161/cc.28751Comment on: Kim HK, et al.",Non-OADS,/arxiv_data1/oa_pdf/e7/0c/cc-13-1366.PMC4050130.pdf
"Cell 2014; 156:158-69; PMID:24361105; http://dx.doi.org/10.1016/j.cell.2013.11.031Crosstalk between the Arg/N-end and   Ac/N-end rule Jeong-Mok Kim and Cheol- sang Hwang* department of Life s ciences; Pohang u niversity of s cience and t echnology; Pohang, Gyeongbuk, s outh Korea",OADS,/arxiv_data1/oa_pdf/e7/0c/cc-13-1366.PMC4050130.pdf
Nat Rev Mol Cell Biol 2008; 9:679- 90; PMID:18698327; http://dx.doi.org/10.1038/ nrm2468 2.,OADS,/arxiv_data1/oa_pdf/e7/0c/cc-13-1366.PMC4050130.pdf
Science 1986; 234:179-86; PMID:3018930; http://dx.doi.org/10.1126/ science.3018930 3.,Non-OADS,/arxiv_data1/oa_pdf/e7/0c/cc-13-1366.PMC4050130.pdf
Nat Rev Mol Cell Biol 2011; 12:735-47; PMID:22016057; http://dx.doi.org/10.1038/ nrm3217 5.,OADS,/arxiv_data1/oa_pdf/e7/0c/cc-13-1366.PMC4050130.pdf
Trends Biochem Sci 2012; 37:152-61; PMID:22405572; http://dx.doi.org/10.1016/j.tibs.2012.02.003 6.,OADS,/arxiv_data1/oa_pdf/e7/0c/cc-13-1366.PMC4050130.pdf
Science 2010; 327:973-7; PMID:20110468; http://dx.doi.org/10.1126/ science.1183147 7.,Non-OADS,/arxiv_data1/oa_pdf/e7/0c/cc-13-1366.PMC4050130.pdf
Mol Cell 2013; 50:540-51;  PMID:23603116; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e7/0c/cc-13-1366.PMC4050130.pdf
Cell 2014; 156:158-69; PMID:24361105; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e7/0c/cc-13-1366.PMC4050130.pdf
"Cell Cycle 13:9, 1368–1369; May 1, 2014; © 2014 Landes Bioscience CeLL  CyCLe News & Views 1368 Cell Cycle Volume 13 issue 9CeLL  CyCLe News & Views How to eliminate a partner for good Comment on: Wang Z, et al Cell Cycle 2014; 13:119–30;  PMID:24608870; http://dx.doi.org/10.4161/cc.28296 Takayoshi Ishii and Andreas Houben*; Leibniz-Institute of Plant Genetics and Crop Plant Research (IPK); Gatersleben, Germany;   *Email: houben@ipk-gatersleben.de; http://dx.doi.org/10.4161/cc.28752 in hybrid cells formed by artificial cell  fusion or sexual hybridization, 2 different  parental genomes are combined within one  cell.",Non-OADS,/arxiv_data1/oa_pdf/c2/13/cc-13-1368.PMC4050131.pdf
"www.landesbioscience.com Cell Cycle 1369References 1. w ang Z, et al Cell Cycle 2014; 13:119-130;  PMiD:24608870; http://dx.doi.org/10.4161/ cc.28296 2. w asmuth J J.",OADS,/arxiv_data1/oa_pdf/c2/13/cc-13-1368.PMC4050131.pdf
3.1.1-3.1.4; http://dx.doi.org/10.1002/0471142905.,Non-OADS,/arxiv_data1/oa_pdf/c2/13/cc-13-1368.PMC4050131.pdf
Trends Mol Med 2006; 12:440- 50; PM iD:16899408; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c2/13/cc-13-1368.PMC4050131.pdf
Trends Biochem s ci 2000; 25:173- 8; PM iD:10754549; http://dx.doi.org/10.1016/ s0968-0004(00)01560-7 5.,OADS,/arxiv_data1/oa_pdf/c2/13/cc-13-1368.PMC4050131.pdf
"Goday C. J Cell s ci 2002; 115:4765-75;  PMiD:12432065; http://dx.doi.org/10.1242/   jcs.00172 6. s anei M, et al.",OADS,/arxiv_data1/oa_pdf/c2/13/cc-13-1368.PMC4050131.pdf
Proc Natl Acad s ci U s A 2011;  108: e498-505; PM iD:21746892; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/13/cc-13-1368.PMC4050131.pdf
Chromosome Res 2010; 18:821- 31; PM iD:20953694; http://dx.doi.org/10.1007/ s10577-010-9158-3v,OADS,/arxiv_data1/oa_pdf/c2/13/cc-13-1368.PMC4050131.pdf
"Cell Cycle 2014; 13:1450–55;  PMID:24626182; http://dx.doi.org/10.4161/cc.28417 Konstantina Rowald and Rocio Sotillo*; Mouse Biology Unit; European Molecular Biology Laboratory (EMBL); Monterotondo, Italy;   *Email: sotillo@embl.it; http://dx.doi.org/10.4161/cc.28753 Fighting cancer is like fighting evolution.",Non-OADS,/arxiv_data1/oa_pdf/b8/05/cc-13-1370.PMC4050132.pdf
Nat Rev Cancer 2010; 10:102- 15; PM iD:20094045; http://dx.doi.org/10.1038/ nrc2781 2.,Non-OADS,/arxiv_data1/oa_pdf/b8/05/cc-13-1370.PMC4050132.pdf
s emin Cell Dev Biol 2013; 24:370- 9; PM iD:23416057; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/05/cc-13-1370.PMC4050132.pdf
J Cell Biol 2013; 201:385 -93;  PMiD:23609535; http://dx.doi.org/10.1083/ jcb.201210018 5.,Non-OADS,/arxiv_data1/oa_pdf/b8/05/cc-13-1370.PMC4050132.pdf
Proc Natl Acad s ci U s A 2012;  109:20549-54; PM iD:23184991; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/05/cc-13-1370.PMC4050132.pdf
"Cell Cycle 2014; 13:1489–94;   PMID:24626178; http://dx.doi.org/10.4161/cc.28471 Luca Valenti1,2,* and Paola Dongiovanni2; 1Department of Pathophysiology and Transplantation; Università degli Studi di Milano; Milan, Italy;   2Internal Medicine; Fondazione IRCCS Ca’ Granda Ospedale Policlinico Milano; Milan, Italy; *Email: luca.valenti@unimi.it;   http://dx.doi.org/10.4161/cc.28754 Nonalcoholic fatty liver disease (NAF lD)  encompasses a wide spectrum, ranging from  simple fatty liver, a relatively benign condi - tion, to nonalcoholic steatohepatitis (NA sH),  characterized by varying degrees of inflamma - tion and fibrosis, with possible progression to cirrhosis and hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/e1/6c/cc-13-1371.PMC4050133.pdf
Gastroenterology 2006; 130:207-10;  PMiD:16401483; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/e1/6c/cc-13-1371.PMC4050133.pdf
Curr Pharm Des 2013; 19:5219- 38; PM iD:23394097; http://dx.doi.org/10.2174/1381 6128113199990381 3.,Non-OADS,/arxiv_data1/oa_pdf/e1/6c/cc-13-1371.PMC4050133.pdf
Nat Genet 2008; 40:1461-5;  PMiD:18820647; http://dx.doi.org/10.1038/ng.257 4.,Non-OADS,/arxiv_data1/oa_pdf/e1/6c/cc-13-1371.PMC4050133.pdf
Hepatology 2010; 51:1209-17;  PMiD:20373368; http://dx.doi.org/10.1002/ hep.23622 5.,Non-OADS,/arxiv_data1/oa_pdf/e1/6c/cc-13-1371.PMC4050133.pdf
J Hepatol 2013; 58:549-56; PMiD:23142622; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/6c/cc-13-1371.PMC4050133.pdf
Cell Cycle 2014; 13; PMiD:24626178; http://dx.doi.org/10.4161/ cc.28471 7.,OADS,/arxiv_data1/oa_pdf/e1/6c/cc-13-1371.PMC4050133.pdf
J Hepatol 2013; 58:399-401;  PMiD:23000435; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/6c/cc-13-1371.PMC4050133.pdf
"*Correspondence to: Andrew Burgess; Email: a.burgess@garvan.org.au Submitted: 12/02/2013; Revised: 02/14/2014; Accepted: 03/02/2014; Published Online: 03/06/2014http://dx.doi.org/10.4161/cc.28401Partial inhibition of Cdk1 in G2 phase overrides   the SAC and decouples mitotic events Rachael A McCloy1, Samuel Rogers1, C e lizabeth Caldon1,2, thierry Lorca3, Anna Castro3, and Andrew Burgess1,2,* 1the Kinghorn Cancer Centre; Garvan Institute of Medical Research; Sydney, New South Wales, Australia; 2St.",Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Science 1996; 274:1672- 7; PMID:8939849 ; http://dx.doi.org/10.1126/ science.274.5293.1672 2.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Oncogene  2009; 28:2925-39;  PMID:19561645 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Semin Cancer Biol 1995; 6:63-72; PMID:7647308 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Science 2009; 325:1682-6; PMID:19779198 ;  http://dx.doi.org/10.1126/science.1172867 5.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Curr Biol 2012;  22:R966-80;  PMID:23174302 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Nat Cell Biol 2013;  15:1378-85;  PMID:24096242 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Nat Rev Mol Cell Biol 2011; 12:427-38; PMID:21633387 ; http://dx.doi.org/10.1038/ nrm3132 8.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Proc Natl Acad Sci U S A 2006;  103:10660-5;  PMID:16818887 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Cell Mol Life Sci 2010; 67:3725- 37; PMID:20496096 ; http://dx.doi.org/10.1007/ s00018-010-0401-z 10.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Chem Biol 2012; 19:1028- 40; PMID:22921070 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
J Cell Biol 2007; 179:671-85; PMID:18025303 ; http://dx.doi.org/10.1083/ jcb.200704117 13.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Dev Cell 2010; 18:533-43;  PMID:20412769 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Nature 2006; 440:954-8; PMID:16612388 ;  http://dx.doi.org/10.1038/nature04652 15.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
EMBO J 2009; 28:2777-85;  PMID:19696736 ; http://dx.doi.org/10.1038/ emboj.2009.238 16.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Proc Natl Acad Sci U S A 2010; 107:12564- 9; PMID:20538976 ; http://dx.doi.org/10.1073/ pnas.0914191107 17.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Science  2010; 330:1670-3;  PMID:21164013 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Science 2010; 330:1673-7; PMID:21164014 ;  http://dx.doi.org/10.1126/science.1197048 20.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
EMBO J 2009; 28:2786- 93; PMID:19680222 ; http://dx.doi.org/10.1038/ emboj.2009.228 21.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
J Cell Biol 2009;  185:193-202;  PMID:19364923 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Genes Cancer 2012; 3:712-20; PMID:23634258 ;  http://dx.doi.org/10.1177/1947601912473478 23.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Nat Cell Biol 2013; 15:430- 9; PMID:23455478 ; http://dx.doi.org/10.1038/ ncb2695 24.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Cell Prolif 2011;  44:391-400;  PMID:21951282 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
J Cell Biol 2012; 198:491-9;  PMID:22908307 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Exp Cell Res 2006; 312:1831-42; PMID:16600213 ;  http://dx.doi.org/10.1016/j.yexcr.2006.02.018 27.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Mol Biol Cell 2011; 22:1191-206;  PMID:21325631 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
J Cell Biol  2005; 168:21-8;  PMID :15631988 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
J Cell Sci 2011; 124:338-47; PMID:21224392 ;  http://dx.doi.org/10.1242/jcs.078329 31.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Oncogene 2011; 30:2799-809;  PMID:21339734 ; http://dx.doi.org/10.1038/ onc.2011.30 32.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Int J Cancer 2013; 132:1505-15; PMID:22945332 ;  http://dx.doi.org/10.1002/ijc.27810 33.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Oncogene 2014; 33:116-28; PMID:23524583 ;  http://dx.doi.org/10.1038/onc.2013.96 34.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Crit Rev Oncog 2012; 17:175-98;  PMID:22471707; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
J Cell Biol 2009; 186:675-84; PMID:19720871 ;  http://dx.doi.org/10.1083/jcb.200906150 36.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Mol  Cancer Ther 2009; 8:1646-54; PMID:19509263 ;  http://dx.doi.org/10.1158/1535-7163.MCT-08-1084 37.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Cancer Cell 2008; 14:111-22;  PMID:18656424 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Nature 2010; 468:1074-9;  PMID:21179163 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Mol Cell  2013; 52:393-405;  PMID:24120663 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Nat Cell Biol 2007; 9:436-44; PMID:17351640 ; http://dx.doi.org/10.1038/ ncb1557 43.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
J Cell Biol 2010; 189:247-59; PMID:20404109 ; http://dx.doi.org/10.1083/ jcb.200909144 45.,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
Cell Cycle  2010; 9:3591-601;  PMID:20818157 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
PLoS One 2012; 7:e45726; PMID:23029203 ;  http://dx.doi.org/10.1371/journal.pone.0045726,Non-OADS,/arxiv_data1/oa_pdf/80/77/cc-13-1400.PMC4050138.pdf
"24 When DNA lesions are severe or irreparable,  *Correspondence to: Tatiana V Pospelova; Email: tvpgroup@mail.ru Submitted: 02/24/2014; Accepted: 03/02/2014; Published Online: 03/07/2014http://dx.doi.org/10.4161/cc.28402Sustained activation of DNA damage response   in irradiated apoptosis-resistant cells   induces reversible senescence associated   with mTOR downregulation and expression   of stem cell markers Zhanna V Chitikova, Serguei A Gordeev, t atiana V Bykova, Svetlana G Zubova, Valery A p ospelov, and t atiana V p ospelova* Institute of Cytology; Russian Academy of Sciences; St. p etersburg, Russia; Saint p etersburg State University; St. p etersburg, Russia Keywords:  apoptosis resistance, DNA damage response, DNA repair, polyploidy, mTOR, autophagy, stem cells markers,   senescence reversion Cells respond to genotoxic stress by activating the DNA damage response (DDR).",Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell 1997 ; 88:593-602; PMID:9054499 ;  http://dx.doi.org/10.1016/S0092-8674(00)81902-9 3.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Oncogene  1998 ; 16:1113 -23; PMID:9528853 ;  http://dx.doi.org/10.1038/sj.onc.1201862 6.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Exp Cell Res 2004 ; 295:525- 38; PMID :15093749 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell Death Differ  2006 ; 13:1960 -7; PMID:16557274 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Exp Cell Res 1965 ;  37:614-36; PMID :14315085 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Proc Natl Acad Sci U S A 1995 ; 92:9363 - 7; PMID:7568133 ; http://dx.doi.org/10.1073/ pnas.92.20.9363 10.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Nat Cell Biol 2009 ; 11:973- 9; PMID:19597488 ; http://dx.doi.org/10.1038/ ncb1909 12.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Gene  2007 ; 397:84-93;  PMID:17544228 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell 2003 ;  113:703-16; PMID:12809602 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell 2002 ; 110:163-75; PMID :12150925 ;  http://dx.doi.org/10.1016/S0092-8674(02)00808-5 17.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Curr Biol   2004 ; 14:1296 -302; PMID :15268862 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Genes Dev 2009 ; 23:798- 803; PMID:19279323 ; http://dx.doi.org/10.1101/ gad.519709 19.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
FEBS Lett  2010 ; 584:1287 - 95; PMID:20083114 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
J Biol Chem  1998 ; 273:5858 -68; PMID:9488723 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
J Cell Biol  2001 ; 153:613-20; PMID:11331310 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Nature  2003 ; 421:499- 506; PMID:12556884 ; http://dx.doi.org/10.1038/ nature01368 24.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Mutat Res  2012 ; 751:158-246;  PMID:22743550 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Genes Dev 2007 ; 21:879-85; PMID:17437994 ;  http://dx.doi.org/10.1101/gad.1550307 26.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Nat Cell Biol 2002 ; 4:993- 7; PMID:12447390 ; http://dx.doi.org/10.1038/ ncb884 27.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
DNA Repair (Amst) 2007 ; 6:1536 - 44; PMID:17553757 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Nature  2006 ; 444:638- 42; PMID:17136094 ; http://dx.doi.org/10.1038/ nature05327 29.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
J Cell Sci  2012 ; 125:5280 -7; PMID:22899723 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Nature   2003 ; 426:194-8; PMID:14608368 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Epigenetics Chromatin  2008 ; 1:6; PMID :19014415 ;  http://dx.doi.org/10.1186/1756-8935-1-6 32.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Sci Transl Med 2011 ; 3:89ra58 ;  PMID :21715679 ; http://dx.doi.org/10.1126/ scitranslmed.3002346 36.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell Cycle  2012 ; 11:2402 -7;  PMID:22672902 ; http://dx.doi.org/10.4161/ cc.20882,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
EMBO J 2003 ; 22:4212 -22; PMID:12912919 ;  http://dx.doi.org/10.1093/emboj/cdg417 38.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Nature  1988 ;  334:124-9; PMID:2968522 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell 1991 ;  65:1053 -61; PMID:1828392 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell 1990 ;  62:659-69; PMID:2143697 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Nature  1993 ;  365:349-52; PMID:8377827 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Nat Cell Biol 2012 ; 14:355- 65; PMID:22426077 ; http://dx.doi.org/10.1038/ ncb2466 45.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Radiat Res 2012 ; 178:AV35 - 42; PMID:22870978 ; http://dx.doi.org/10.1667/ RR AV04.1 46.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Exp Cell Res  1988 ; 175:184-91;  PMID:3345800 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell Cycle  2011 ; 10:457- 68; PMID:21248468 ; http://dx.doi.org/10.4161/ cc.10.3.1470751.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell Cycle  2011 ;  10:3658 -77; PMID:22052357 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell Cycle  2013 ; 12:3841 - 51; PMID:24296616 ; http://dx.doi.org/10.4161/ cc.27396 53.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Exp Cell Res 2010 ; 316:2099 -112; PMID:20457152 ;  http://dx.doi.org/10.1016/j.yexcr.2010.04.030 54.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Nat Cell Biol  2004 ; 6:168-70; PMID:14755273 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Genes  Dev 2007 ; 21:43-8; PMID:17210786 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
J Cell Biol 2007 ; 178:1101- 8; PMID:17893239 ; http://dx.doi.org/10.1083/ jcb.200704140 57.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Nat Rev Genet 2005 ; 6:836- 46; PMID:16304599 ; http://dx.doi.org/10.1038/ nrg1711 58.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cancer Cell  2003 ; 3:445-8; PMID:12781362 ;  http://dx.doi.org/10.1016/S1535-6108(03)00114-4 59.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Nat Commun  2012 ; 3:815;  PMID:22569363 ; http://dx.doi.org/10.1038/ ncomms1825 60.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Mol Cell Biol  2009 ; 29:5645 - 56; PMID:19704005 ; http://dx.doi.org/10.1128/ MCB.00711-09 61.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Proc Natl Acad Sci U S A 2005 ; 102:8204 - 9; PMID :15928081 ; http://dx.doi.org/10.1073/ pnas.0502857102 62.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Proc Natl Acad Sci U S A  2010 ; 107:9660 -4; PMID:20457898 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell Cycle  2009 ;  8:1888 -95; PMID:19471117 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell Cycle   2012 ; 11:2391 -401; PMID:22627671 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Aging Cell   2011 ; 10:908-11; PMID :21615676 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell Stem Cell   2009 ; 4:301-12; PMID:19341620 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell Rep   2013 ; 3:651-60; PMID:23478019 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Stem Cells  2013 ; 31:1726 -30;  PMID:23630174 ; http://dx.doi.org/10.1002/ stem.1406 72.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
J Clin Invest 2012 ;  122:4077 -93; PMID:23093782 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Oncogene   2011 ; 30:3833 -45; PMID:21499299 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cancer Res 2010 ;  70:10433 -44; PMID:21159654 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Nat Genet  2008 ; 40:499-507; PMID:18443585 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell Biol Int 2011 ; 35:687-95;  PMID:21250945 ; http://dx.doi.org/10.1042/ CBI20100762 81.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell Biol Int 2008 ; 32:1031 - 43; PMID:18550395 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Cell Biol Int  2009 ; 33:702-3; PMID:19303938 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
Methods Mol Biol  2013 ; 965:383- 408; PMID:23296673 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/38/cc-13-1424.PMC4050140.pdf
"Many studies have implied that replication forks can pause or stall naturally at telomeres in yeast 16-18 and in human primary fibro - blasts.19 In agreement with these thoughts, there is mounting evi - dence suggesting that telomeres behave like fragile sites.11,12,20 -2 3 In  particular, increased replication stress either by ATR deficiency,20  or by drugs such as aphidicolin and hydroxyurea, which render  *Correspondence to: Maria A Blasco; Email: mblasco@cnio.es Submitted: 02/14/2014; Accepted: 03/03/2014; Published Online: 03/10/2014http://dx.doi.org/10.4161/cc.28419TopoII α prevents telomere fragility and formation  of ultra thin DNA bridges during mitosis through  TRF1-dependent binding to telomeres Martina Stagno d’Alcontres1, Jose Alejandro pa lacios1, Diego Mejias2, and Maria A Blasco1,* 1te lomeres and te lomerase Group; Molecular on cology pr ogramme; Spanish National Cancer Research Centre (CNI o) ; Madrid, Spain; 2Confocal Microscopy Unit;  Biotechnology  pr ogramme; Spanish National Cancer Research Centre (CNI o) ; Madrid, Spain Keywords:  SAC, Shelterin, TRF1, TopoII, fragility, mitosis te lomeres are repetitive nucleoprotein structures at the ends of chromosomes.",Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Rev Genet 2007; 8:299- 309; PMID:17363977 ; http://dx.doi.org/10.1038/ nrg2047 3.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Annu Rev Genet 2008; 42:301-34; PMID:18680434 ; http://dx.doi.org/10.1146/ annurev.genet.41.110306.130350 4.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cell 1997; 91:25-34; PMID:9335332 ;  http://dx.doi.org/10.1016/S0092-8674(01)80006-4 5.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Science 1995; 270:1663-7; PMID:7502076 ; http://dx.doi.org/10.1126/ science.270.5242.1663 7.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nature 1997; 385:740-3;  PMID:9034193 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Mol Cell Biol 2003; 23:6533-41; PMID:12944479 ; http://dx.doi.org/10.1128/ MCB.23.18.6533-6541.2003 10.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
J Biol Chem 2008; 283:23981-8;  PMID :18587156 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Genes Dev 2009; 23:2060-75; PMID:19679647 ;  http://dx.doi.org/10.1101/gad.543509 12.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cell 2009; 138:90-103; PMID:19596237 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Annu Rev Genet 2007; 41:169-92; PMID:17608616 ; http://dx.doi.org/10.1146/ annurev.genet.41.042007.16590014.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
PLoS Genet 2009; 5:e1000475; PMID:19424434 ;  http://dx.doi.org/10.1371/journal.pgen.1000475 15.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Curr Pharm Des 2012; 18:1867-72; PMID:22376109 ;  http://dx.doi.org/10.2174/138161212799958404 16.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Genes Dev 2002; 16:1383-96;  PMID:12050116 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Mol Cell Biol 2004; 24:4019-31; PMID:15082794 ; http://dx.doi.org/10.1128/ MCB.24.9.4019-4031.2004 18.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cell 2006; 127:709-20;  PMID:17110331 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
J Cell Biol 2010; 188:639-52; PMID :20212315 ; http://dx.doi.org/10.1083/ jcb.200908136 21.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Dev Cell 2010; 18:775-89; PMID:20493811 ;  http://dx.doi.org/10.1016/j.devcel.2010.03.011 22.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cell 2012; 149:795-806; PMID:22579284 ;  http://dx.doi.org/10.1016/j.cell.2012.03.030 23.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Science 2013; 342:239-42; PMID :24115439 ; http://dx.doi.org/10.1126/ science.1241779 24.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Cell Biol 2010; 12:768-80; PMID:20622869 ;  http://dx.doi.org/10.1038/ncb208125.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Genes Dev 2007; 21:1921-36; PMID:17671091 ; http://dx.doi.org/10.1101/ gad.432107 26.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
EMBO J 2009; 28:2803-11; PMID:19680223 ; http://dx.doi.org/10.1038/ emboj.2009.223 27.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cell 1980; 20:461-7; PMID:6248247 ;  http://dx.doi.org/10.1016/0092-8674(80)90632-7 28.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cell 1980; 21:115-25;  PMID:6250707 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cell 1980; 19:697-707; PMID:6244895 ;  http://dx.doi.org/10.1016/S0092-8674(80)80046-8 31.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Rev Mol Cell Biol 2011; 12:827-41;  PMID:22108601 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cell 2010; 142:230-42; PMID:20655466 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cell 2007; 128:101-14; PMID:17218258 ;  http://dx.doi.org/10.1016/j.cell.2006.11.041 35.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
EMBO J 2007; 26:3397-409; PMID:17599064 ;  http://dx.doi.org/10.1038/sj.emboj.7601777 36.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nature 2003; 426:870-4; PMID:14685245 ;  http://dx.doi.org/10.1038/nature02253,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Mol Cell Biol 2006; 26:6299-307; PMID:16880537 ; http://dx.doi.org/10.1128/ MCB.00702-06 39.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Chromosoma 2008; 117:123-35; PMID:17989990 ; http://dx.doi.org/10.1007/ s00412-007-0131-7 40.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Rev Mol Cell Biol 2007; 8:379-93;  PMID:17426725 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
EMBO J 2001; 20:6648-59;  PMID:11726501 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
J Cell Biol 2001; 154:925-36;  PMID :11535616 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Dev Cell 2009; 16:118-31;  PMID:19154723 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cell Cycle 2005; 4:121-4;  PMID :15611654 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Mol Cell Biol 2009; 29:1608-25; PMID:19124610 ; http://dx.doi.org/10.1128/ MCB.01339-08 48.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
J Cell Biol 2009; 187:165-73; PMID:19822671 ;  http://dx.doi.org/10.1083/jcb.200903096 49.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cell Cycle 2012; 11:797-806; PMID:22374677 ; http://dx.doi.org/10.4161/ cc.11.4.19307 50.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
J Biol Chem 2001; 276:44488-94; PMID:11577077 ;  http://dx.doi.org/10.1074/jbc.M104383200 51.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
J Cell Biol 1994; 126:1341-51; PMID:8089169 ; http://dx.doi.org/10.1083/ jcb.126.6.1341 53.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
PLoS One 2010; 5:5; PMID:20862250 ; http://dx.doi.org/10.1371/jour- nal.pone.0012664 55.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Cell Biol 2005; 7:712-8; PMID :15968270 ; http://dx.doi.org/10.1038/ ncb1275 56.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
EMBO J 1999; 18:2950-60; PMID:10357808 ; http://dx.doi.org/10.1093/ emboj/18.11.2950 57.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
J Biol Chem 2010; 285:1457-67; PMID:19864690 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Oncogene 2006; 25:3598-605;  PMID:16449973 ;  http://dx.doi.org/10.1038/sj.onc.1209392 59.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Mol Biol Cell 2001; 12:1315-28 ;  PMID:11359924 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
FEBS Lett 2002; 514:193-8; PMID :11943150 ; http://dx.doi.org/10.1016/ S0014-5793(02)02363-3 63.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
J Cell Biol 2012; 197:283-300;  PMID:22508511 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Curr Biol 2002; 12:1797-806; PMID:12419179 ;  http://dx.doi.org/10.1016/S0960-9822(02)01226-5 65.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Cell Biol 2000; 2:90-5; PMID:10655588 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cancer Res 2010; 70:2041-52; PMID:20160025 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-200867.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Exp Cell Res 1999; 252:50-62; PMID:10502399 ;  http://dx.doi.org/10.1006/excr.1999.4616 68.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nucleic Acids Res 2012; 40:7358-67; PMID:22576367 ;  http://dx.doi.org/10.1093/nar/gks407 69.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
EMBO J 2011; 30:3309-21;  PMID:21743438 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
PLoS One 2012; 7:e33905; PMID:22563370 ;  http://dx.doi.org/10.1371/journal.pone.0033905 71.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Genet 2000; 26:447-50; PMID:11101843 ; http://dx.doi.org/10.1038/82586 72.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Hum Mol Genet 2002; 11:3135-44; PMID:12444098 ;  http://dx.doi.org/10.1093/hmg/11.25.3135 73.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Genet 2008; 40:362-6;  PMID:18246067 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Cell Biol 2013; 15:96-102; PMID :23242215 ; http://dx.doi.org/10.1038/ ncb2643 75.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Genet 2004; 36:744-9; PMID:15208629 ; http://dx.doi.org/10.1038/ng1382 76.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nature 1998; 392:569-74;  PMID :9560153 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
EMBO Rep 2001; 2:800-7; PMID:11520856 ;  http://dx.doi.org/10.1093/embo-reports/kve174 78.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Rev Cancer 2005; 5:773-85; PMID:16195750 ;  http://dx.doi.org/10.1038/nrc1714 80.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cell 2003; 114:87-98;  PMID:12859900 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
J Cell Biol 2005; 170:873-80; PMID:16144904 ; http://dx.doi.org/10.1083/ jcb.200505040 82.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
J Cell Sci 2010; 123:84-94;  PMID:20016069 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
J Cell Sci 2011; 124:1664-71; PMID :21511728 ; http://dx.doi.org/10.1242/ jcs.081216 84.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Cancer Cell 2012; 21:765-76;  PMID:22698402 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Struct Mol Biol 2012; 19:387-94; PMID:22407014 ; http://dx.doi.org/10.1038/ nsmb.2245 86.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Science 2002; 296:550-3; PMID:11910072 ; http://dx.doi.org/10.1126/ science.1068999 87.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Mol Cell Biol 2000; 20:8602-12; PMID:11046155 ; http://dx.doi.org/10.1128/ MCB.20.22.8602-8612.200088.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Genet 2004; 36:94-9; PMID:14702045 ; http://dx.doi.org/10.1038/ng1278 89.,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
Nat Genet 2005; 37:1063-71; PMID:16142233 ; http://dx.doi.org/10.1038/ ng1633,OADS,/arxiv_data1/oa_pdf/5b/16/cc-13-1463.PMC4050144.pdf
"This syner - getic approach will allow us to establish  *Correspondence to: B Tracy Nixon; Email: btn1@psu.edu Submitted: 02/27/2014; Accepted: 03/05/2014; Published Online: 04/22/2014http://dx.doi.org/10.4161/cc.28957Comment on: Sysoeva TA, et al.",Non-OADS,/arxiv_data1/oa_pdf/8c/82/cc-13-1509.PMC4050149.pdf
"Genes Dev 2013; 27:2500-11; PMID:24240239; http://dx.doi.org/10.1101/gad.229385.113Breaking symmetry in multimeric ATPase motors tatyana a s ysoeva†, saikat Chowdhury‡, and B t racy Nixon* department of Biochemistry and Molecular Biology; t he Pennsylvania s tate u niversity; u niversity Park, P a usa Current affiliations: †department of Molecular and Cellular Biology; Harvard u niversity; Cambridge, M a usa ;   ‡department of i ntegrative s tructural and Computational Biology; t he s cripps r esearch i nstitute; l a Jolla, C a usa",Non-OADS,/arxiv_data1/oa_pdf/8c/82/cc-13-1509.PMC4050149.pdf
Genes Dev 2003; 17:2552-63;  PMID:14561776; http://dx.doi.org/10.1101/ gad.1125603 2.,OADS,/arxiv_data1/oa_pdf/8c/82/cc-13-1509.PMC4050149.pdf
Science 2005; 307:1972-5; PMID:15790859; http://dx.doi.org/10.1126/ science.1105932 3.,OADS,/arxiv_data1/oa_pdf/8c/82/cc-13-1509.PMC4050149.pdf
Structure 2007; 15:429-40;  PMID:17437715; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/82/cc-13-1509.PMC4050149.pdf
Structure 2010; 18:1420-30; PMID:21070941; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/82/cc-13-1509.PMC4050149.pdf
Genes Dev 2013; 27:2500-11;  PMID:24240239; http://dx.doi.org/10.1101/ gad.229385.113 6.,OADS,/arxiv_data1/oa_pdf/8c/82/cc-13-1509.PMC4050149.pdf
Nature 2006; 442:270-5;  PMID:16855583; http://dx.doi.org/10.1038/ nature04943 7.,OADS,/arxiv_data1/oa_pdf/8c/82/cc-13-1509.PMC4050149.pdf
Cell 2009; 139:523-34;  PMID:19879839; http://dx.doi.org/10.1016/j.cell.2009.08.043 Figure 1.  the functional role of asymmetry in a aaa + atPase homo-hexameric motor.,OADS,/arxiv_data1/oa_pdf/8c/82/cc-13-1509.PMC4050149.pdf
"We pro - pose the concept of “extended phenotype” to functionally define human HSCs that  *Correspondence to: Mickie Bhatia; Email: mbhatia@mcmaster.ca Submitted: 03/04/2014; Accepted: 03/10/2014; Published Online: 04/22/2014http://dx.doi.org/10.4161/cc.28958Comment on: Guezguez B, et al.",Non-OADS,/arxiv_data1/oa_pdf/b9/f5/cc-13-1511.PMC4050150.pdf
"Cell Stem Cell 2013; 13:175-89; PMID:23910084; http://dx.doi.org/10.1016/j.stem.2013.06.015Driving human–mouse avatars to understand   the HSC niche Borhane Guezguez1 and Mickie Bhatia1,2,* 1McMaster s tem Cell and Cancer r esearch i nstitute ( sCC-ri); McMaster u niversity; Faculty of Health s ciences; Hamilton, o ntario, Canada;   2department of Biochemistry and Biomedical s ciences; Faculty of Health s ciences; McMaster u niversity; Hamilton, o ntario, Canada",Non-OADS,/arxiv_data1/oa_pdf/b9/f5/cc-13-1511.PMC4050150.pdf
Ann N Y Acad Sci 2012;  1266:138-50;  PMID:22901265 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b9/f5/cc-13-1511.PMC4050150.pdf
Cytotherapy 2010; 12:121- 30; PMID:20196692 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b9/f5/cc-13-1511.PMC4050150.pdf
Curr Opin Hematol 2012; 19:250-5; PMID:22504524 ; http://dx.doi.org/10.1097/ MOH.0b013e328353c714 4.,Non-OADS,/arxiv_data1/oa_pdf/b9/f5/cc-13-1511.PMC4050150.pdf
Nat Rev Mol Cell Biol 2011; 12:643- 55; PMID:21886187 ; http://dx.doi.org/10.1038/ nrm3184 5.,OADS,/arxiv_data1/oa_pdf/b9/f5/cc-13-1511.PMC4050150.pdf
Nature 2014; 505:327-34; PMID:24429631 ; http://dx.doi.org/10.1038/ nature12984 6.,Non-OADS,/arxiv_data1/oa_pdf/b9/f5/cc-13-1511.PMC4050150.pdf
Nat Rev Immunol 2012; 12:786- 98; PMID:23059428 ; http://dx.doi.org/10.1038/ nri3311 7.,Non-OADS,/arxiv_data1/oa_pdf/b9/f5/cc-13-1511.PMC4050150.pdf
Cell Stem Cell 2013; 13:175-89; PMID:23910084 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b9/f5/cc-13-1511.PMC4050150.pdf
Exp Hematol 2012; 40:685-94;  PMID:22640993 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b9/f5/cc-13-1511.PMC4050150.pdf
"2 In fact, a proof- of-principle study on ovarian cancer cells revealed that auranofin indeed augmented  *Correspondence to: Ansgar Brüning; Email: ansgar.bruening@med.uni-muenchen.de Submitted: 03/05/2014; Accepted: 03/16/2014; Published Online: 04/22/2014http://dx.doi.org/10.4161/cc.28959Comment on: Papaioannou M, et al.",Non-OADS,/arxiv_data1/oa_pdf/b5/7e/cc-13-1513.PMC4050151.pdf
Drug Alcohol Rev 2013; 32:342- 4; PMID:23194431 ; http://dx.doi.org/10.1111/ dar.12018 2.,Non-OADS,/arxiv_data1/oa_pdf/b5/7e/cc-13-1513.PMC4050151.pdf
Cancer Res 2006; 66:10425-33;  PMID:17079463 ; http://dx.doi.org/10.1158/0008- 5472.CAN-06-2126 4.,Non-OADS,/arxiv_data1/oa_pdf/b5/7e/cc-13-1513.PMC4050151.pdf
PLoS One 2013; 8:e78130;  PMID:24194908 ; http://dx.doi.org/10.1371/jour - nal.pone.0078130 6.,Non-OADS,/arxiv_data1/oa_pdf/b5/7e/cc-13-1513.PMC4050151.pdf
Cvek B. Curr Cancer Drug Targets 2011; 11:332-7;  PMID:21247389 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/7e/cc-13-1513.PMC4050151.pdf
"Consistent with asymmetric die ‑1 expres - sion in AWC OFF, die‑1 is required for the  *Correspondence to: Chiou-Fen Chuang; Email: chiou-fen.chuang@cchmc.org Submitted: 03/18/2014; Accepted: 04/23/2014; Published Online: 04/25/2014http://dx.doi.org/10.4161/cc.29010Comment on: Cochella L, et al.",Non-OADS,/arxiv_data1/oa_pdf/00/68/cc-13-1515.PMC4050152.pdf
"Genes Dev 2014; 28:34-43; PMID:24361693; http://dx.doi.org/10.1101/gad.233643.113A molecular link between distinct neuronal  asymmetries amel alqadah1,2, yi-Wen Hsieh1, and Chiou-Fen Chuang1,3,* 1division of d evelopmental Biology; Cincinnati Children’s Hospital r esearch Foundation; Cincinnati, o H usa ; 2Molecular and d evelopmental Biology Graduate Program;  university of Cincinnati; Cincinnati, o H usa ; 3department of Biological s ciences; u niversity of i llinois, Chicago; Chicago, il usa",OADS,/arxiv_data1/oa_pdf/00/68/cc-13-1515.PMC4050152.pdf
Genesis 2014; PMID:24478264;  http://dx.doi.org/10.1002/dvg.22744 3.,OADS,/arxiv_data1/oa_pdf/00/68/cc-13-1515.PMC4050152.pdf
Genes Dev 2014; 28:34-43;  PMID:24361693; http://dx.doi.org/10.1101/ gad.233643.113 4.,OADS,/arxiv_data1/oa_pdf/00/68/cc-13-1515.PMC4050152.pdf
Genes Dev 2005; 19:270-81;  PMID:15625192; http://dx.doi.org/10.1101/gad.1276505 5.,OADS,/arxiv_data1/oa_pdf/00/68/cc-13-1515.PMC4050152.pdf
Cell 2007; 129:787-99;  PMID:17512411; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/68/cc-13-1515.PMC4050152.pdf
Development 2012; 139:4191- 201; PMID:23093425; http://dx.doi.org/10.1242/ dev.083428 7.,Non-OADS,/arxiv_data1/oa_pdf/00/68/cc-13-1515.PMC4050152.pdf
PLoS Genet 2012; 8:e1002864;  PMID:22876200; http://dx.doi.org/10.1371/jour - nal.pgen.1002864Figure 1.  schematic of a WC and as E asymmetry.,OADS,/arxiv_data1/oa_pdf/00/68/cc-13-1515.PMC4050152.pdf
"We think that this  *Correspondence to: Richard W Carthew; Email: r-carthew@northwestern.edu Submitted: 02/13/2014; Accepted: 04/23/2014; Published Online: 04/25/2014http://dx.doi.org/10.4161/cc.29013Comment on: Cassidy JJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/1b/70/cc-13-1517.PMC4050153.pdf
"Cell 2013; 155:1556-67; PMID:24360277; http://dx.doi.org/10.1016/j.cell.2013.10.057microRNAs suppress cellular phenotypic  heterogeneity ritika Giri and r ichard W Carthew* department of Molecular Biosciences; Northwestern u niversity; Evanston, il usa",OADS,/arxiv_data1/oa_pdf/1b/70/cc-13-1517.PMC4050153.pdf
Genome Res 2009; 19:92- 105; PMID:18955434; http://dx.doi.org/10.1101/ gr.082701.108 2.,OADS,/arxiv_data1/oa_pdf/1b/70/cc-13-1517.PMC4050153.pdf
Cell 2012; 149:515-24;  PMID:22541426; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1b/70/cc-13-1517.PMC4050153.pdf
Cell 2013; 155:1556-67;  PMID:24360277; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1b/70/cc-13-1517.PMC4050153.pdf
Cell 2000; 102:349-62; PMID:10975525; http://dx.doi.org/10.1016/ S0092-8674(00)00040-4 5.,OADS,/arxiv_data1/oa_pdf/1b/70/cc-13-1517.PMC4050153.pdf
Genes Dev 2003; 17:2966- 78; PMID:14665671; http://dx.doi.org/10.1101/ gad.1122403 6.,OADS,/arxiv_data1/oa_pdf/1b/70/cc-13-1517.PMC4050153.pdf
Evolution 1959; 13:425-39; http://dx.doi.org/10.2307/2406126 8.,Non-OADS,/arxiv_data1/oa_pdf/1b/70/cc-13-1517.PMC4050153.pdf
Nat Genet 2007; 39:673-7;  PMID:17401365; http://dx.doi.org/10.1038/ng2003Figure 1.,OADS,/arxiv_data1/oa_pdf/1b/70/cc-13-1517.PMC4050153.pdf
"Cell Cycle 2014; 13:762–71;  PMID:24394703; http://dx.doi.org/10.4161/cc.27677 M Ian Phillips; Keck Graduate Institute; Claremont, CA USA; Email: Ian_phillips@kgi.edu; http://dx.doi.org/10.4161/cc.28894 when induced pluripotent stem (iP s) cells  were first discovered in 2007 there was a huge  interest.1,2 The iP s cell technique with a mini - mal number of embryonic transcription fac - tors could turn skin or any other tissue directly  into viable embryonic stem cells.",Non-OADS,/arxiv_data1/oa_pdf/d4/cf/cc-13-1519.PMC4050154.pdf
Cell 2007; 131:861-72;  PMiD:18035408; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/cf/cc-13-1519.PMC4050154.pdf
J Mol Cell Cardiol 2011; 50:327- 32; PM iD:21040726; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/cf/cc-13-1519.PMC4050154.pdf
"Cell Cycle 2014; 13:762-71;  PMiD:24394703; http://dx.doi.org/10.4161/ cc.27677 4. l ee A s, et al.",OADS,/arxiv_data1/oa_pdf/d4/cf/cc-13-1519.PMC4050154.pdf
Nat Med 2013; 19:998-1004;  PMiD:23921754; http://dx.doi.org/10.1038/ nm.3267 5.,Non-OADS,/arxiv_data1/oa_pdf/d4/cf/cc-13-1519.PMC4050154.pdf
Cell s tem Cell 2013; 12:167- 79; PM iD:23318055; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/cf/cc-13-1519.PMC4050154.pdf
J Am Coll Cardiol 2005; 46:1339- 50; PM iD:16198853; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d4/cf/cc-13-1519.PMC4050154.pdf
Clinical pharmacology & thera - peutics (Nature publication) 2012; 92:182-92;  http://dx.doi.org/10.1038/clpt.2012.82,Non-OADS,/arxiv_data1/oa_pdf/d4/cf/cc-13-1519.PMC4050154.pdf
"Cell Cycle 2014; 13:792–800;  PMID:24401748; http://dx.doi.org/10.4161/cc.27725 Sara M Reed1,2, Frederick W Quelle1,3, and Dawn E Quelle1,2,3,4,*; 1Department of Pharmacology; The University of Iowa; Carver College of Medicine;   Iowa City, IA USA; 2Medical Scientist Training Program; The University of Iowa; Carver College of Medicine; Iowa City, IA USA; 3Holden Comprehensive   Cancer Center; The University of Iowa; Carver College of Medicine; Iowa City, IA USA; 4Department of Pathology; The University of Iowa; Carver College   of Medicine; Iowa City, IA USA; *Email: dawn-quelle@uiowa.edu; http://dx.doi.org/10.4161/cc.28900 ARF, the alternative reading frame protein  encoded by the Ink4a–ARF  (Cdkn2a ) locus, is  best known for suppressing cancer through  p53-dependent and p53-independent path - ways.1 Although less widely appreciated, ARF  is also important in development.",Non-OADS,/arxiv_data1/oa_pdf/a5/07/cc-13-1520.PMC4050155.pdf
Nat Rev Cancer  2006 ; 6:663-73;  PMiD:16915296 ; http://dx.doi.org/10.1038/nrc1954 2.,Non-OADS,/arxiv_data1/oa_pdf/a5/07/cc-13-1520.PMC4050155.pdf
Cell Cycle  2005 ; 4:1316 - 9; PM iD:16205116 ; http://dx.doi.org/10.4161/ cc.4.10.2109 3.,OADS,/arxiv_data1/oa_pdf/a5/07/cc-13-1520.PMC4050155.pdf
Proc Natl Acad sci U s A 2009 ;  106:6285 -90; PM iD:19339492 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/07/cc-13-1520.PMC4050155.pdf
"Mol Cell Biol  2012 ; 32:4270 - 82; PM iD:22907756 ; http://dx.doi.org/10.1128/ MCB.0 6 424 -11 5. iqbal  N, et al.",OADS,/arxiv_data1/oa_pdf/a5/07/cc-13-1520.PMC4050155.pdf
Cell Cycle  2014 ; 13:792-800 ;  PMiD:24401748 ; http://dx.doi.org/10.4161/ cc.27725 6.,OADS,/arxiv_data1/oa_pdf/a5/07/cc-13-1520.PMC4050155.pdf
Oncogene  2014 ; 33:300 - 7; PM iD:23318441 ; http://dx.doi.org/10.1038/ onc.2012.601 7.,OADS,/arxiv_data1/oa_pdf/a5/07/cc-13-1520.PMC4050155.pdf
Genes Dev 2009 ; 23:975-85;  PMi D:19390090 ; http://dx.doi.org/10.1101/ gad.1742509 8.,OADS,/arxiv_data1/oa_pdf/a5/07/cc-13-1520.PMC4050155.pdf
Nature  2011 ; 478:349 -55;  PMiD:21993628 ; http://dx.doi.org/10.1038/ nature10502,Non-OADS,/arxiv_data1/oa_pdf/a5/07/cc-13-1520.PMC4050155.pdf
"Cell Cycle 2014; 13:1456–62;  PMID:24626181; http://dx.doi.org/10.4161/cc.28418 Amelia E  Firor  and Alexander  Jares *; Stony Brook University; Stony Brook, NY USA; *Email: alexander.jares@stonybrookmedicine.edu;   http://dx.doi.org/10.4161/cc.28901 in 2006, yamanaka et al.",OADS,/arxiv_data1/oa_pdf/fd/7a/cc-13-1522.PMC4050156.pdf
Cell 2006 ; 126:663-76;  PMiD:16904174 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/7a/cc-13-1522.PMC4050156.pdf
Cell Cycle  2008 ; 7:725-8;  PMiD:18239456 ; http://dx.doi.org/10.4161/ cc.7.6.5573 3.,OADS,/arxiv_data1/oa_pdf/fd/7a/cc-13-1522.PMC4050156.pdf
Nat Cell Biol 2006 ; 8:1114 -23;  PMi D:16980957 ; http://dx.doi.org/10.1038/ ncb1481 4.,OADS,/arxiv_data1/oa_pdf/fd/7a/cc-13-1522.PMC4050156.pdf
Genes Cells 2009 ;  14:683-94; PM iD:19476507 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fd/7a/cc-13-1522.PMC4050156.pdf
N e ngl J Med 2013 ; 368:2266 - 76; PM iD:23758232 ; http://dx.doi.org/10.1056/ NeJMoa1300297 6.,OADS,/arxiv_data1/oa_pdf/fd/7a/cc-13-1522.PMC4050156.pdf
"Blood  2006 ; 108:2726 -35; PM iD:16763212 ;  http://dx.doi.org/10.1182/blood-2006-02-001594 7. w u M, et al.",OADS,/arxiv_data1/oa_pdf/fd/7a/cc-13-1522.PMC4050156.pdf
Cell Cycle 2014; 13; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fd/7a/cc-13-1522.PMC4050156.pdf
"13 Apoptosis plays a critical role in the  *Correspondence to: Claudia Friesen; Email: claudia.friesen@uni-ulm.de Submitted: 02/05/2014; Revised: 03/07/2014; Accepted: 03/10/2014; Published Online: 03/12/2014http://dx.doi.org/10.4161/cc.28493Opioid receptor activation triggering  downregulation of cAMP improves effectiveness  of anti-cancer drugs in treatment of glioblastoma Claudia Friesen1,2,*, Inis Hormann1,2, Mareike Roscher1,2, Iduna Fichtner3, Andreas Alt2, Ralf Hilger4, Klaus-Michael Debatin5,   and e rich Miltner1,2 1Center for Biomedical Research; University of Ulm; Ulm, Germany; 2Institute of Legal Medicine; University of Ulm; Ulm, Germany; 3Max Delbrueck Center for Molecular  Medicine; Berlin, Germany; 4Department of Internal Medicine; University of e ssen; West German Cancer Center; e ssen, Germany; 5University Children’s Hospital;   University of Ulm; Ulm, Germany Keywords:  opioid receptor, cAMP, D,L-methadone, chemoresistance, glioblastoma, glioblastoma stem cells, chemotherapy,  apoptosis Abbrevations:  IAPs, inhibitor of apoptosis proteins; cAMP, cyclic AMP; Doxo, doxorubicin; IBMX, 3-isobutyl-1-methylxanthine;  XIAP, X-linked IAP; p-gp, p-glycoproteins; Caelyx, liposomal encapsulated formulation of doxorubicin Glioblastoma are the most frequent and malignant human brain tumors, having a very poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
"Grant support: This work was  supported by Deutsche Krebshilfe (http://www.krebshilfe.de), Bonn, Germany (grant 109035).",Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Cell Cycle 2013; 12:145-56;  PMID:23255107 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Cell Res 2008; 18:1037- 46; PMID:18679414 ; http://dx.doi.org/10.1038/ cr.2008.2706.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Cell Cycle 2013; 12:1473- 4; PMID:23624839 ; http://dx.doi.org/10.4161/ cc.24747 7.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Acta Physiol (Oxf) 2012; 204:277-87;  PMID:21385327 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Nat Cell Biol  2000; 2:E167-8;  PMID:10980716 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Apoptosis  2010; 15:196-203;  PMID:19882354 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Blood  2009; 114:608-18;  PMID :19451550 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Cell Signal  1997; 9:237-48;  PMID:9218123 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Cancer Res 2008; 68:6059-64;  PMID:18676827 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Leuk Res 2011; 35:1649- 57; PMID:21798596 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Nat Rev Cancer 2002; 2:594-604; PMID :12154352 ; http://dx.doi.org/10.1038/nrc864 16.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Nat Med 1996; 2:574-7; PMID:8616718 ;  http://dx.doi.org/10.1038/nm0596-574 17.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Oncogene 2003; 22:8543-67;  PMID:14634618 ;  http://dx.doi.org/10.1038/sj.onc.1207107 19.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Oncogene 1998; 17:3247- 59; PMID:9916987 ; http://dx.doi.org/10.1038/ sj.onc.1202569 20.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Chemotherapy 2002;  48:189-95;  PMID:12218266 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Cancer 2001; 92:1936-42; PMID:11745268 ; http://dx.doi.org/10.1002/1097- 0142(20011001)92:7<1936::AID-CNCR1712>3.0.CO;2-H 23.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Ann Oncol 2000; 11:1029-33;  PMID:11038041 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Cancer Res 2008; 68:6043-8;  PMID:18676824 ; http://dx.doi.org/10.1158/0008- 5472.CAN-08-1079 25.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Fundam Clin Pharmacol  1999; 13:494-500;  PMID:10456292 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Pharmacology 2007; 80:304-11; PMID:17690563 ;  http://dx.doi.org/10.1159/000107104 29.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Annu Rev Pharmacol Toxicol 2000; 40:389-430;  PMID:10836142 ; http://dx.doi.org/10.1146/ annurev.pharmtox.40.1.389 30.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Int J Cancer 2009; 124:511-5;  PMID:19003982 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Cell  2002; 108:153-64;  PMID:11832206 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Immunol Rev  1991; 121:29-65;  PMID:1937533 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Arch Neurol 2010; 67:279- 83; PMID:20212224 ; http://dx.doi.org/10.1001/ archneurol.2010.5 36.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Biochem Biophys Res Commun 2001; 285:207- 16; PMID:11444827 ; http://dx.doi.org/10.1006/ bbrc.2001.5147 38.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
J Biol Chem 2007; 282:14094-100; PMID:17353197 ;  http://dx.doi.org/10.1074/jbc.M611370200 40.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Pain Med 2008; 9:595-612;  PMID:18565004 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Eur J Pain 2007; 11:823-30;  PMID:17331764 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Clin Cancer Res 2008; 14:8205-12; PMID:19088037 ; http://dx.doi.org/10.1158/1078- 0432.CCR-08-0644 44.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Mol Biol Cell 2008; 19:3283-9; PMID:18508926 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Exp Cell Res  2000; 256:42-9;  PMID:10739650 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Hematology Am Soc Hematol Educ Program  2005:215-9;  PMID:16304383 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Oncogene 2007;  26:1324-37;  PMID:17322918 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
J Neurochem 2008;  107:871-82;  PMID:18786178 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Cancer Res  2008; 68:6271-80;  PMID:18676851 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Clin Cancer Res 2011; 17:4019-30; PMID :21525171 ; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0075 53.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Cell Death Differ 2006; 13:1238-41; PMID:16456578 ; http://dx.doi.org/10.1038/ sj.cdd.4401872 54.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
J Immunol Methods  1991; 139:271-9;  PMID:1710634 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Cell Death Differ 2004;  11(Suppl 1):S73-85;  PMID :15105835 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
Br J Cancer 2010; 102:1555-77; PMID:20502460 ;  http://dx.doi.org/10.1038/sj.bjc.6605642,Non-OADS,/arxiv_data1/oa_pdf/8f/54/cc-13-1560.PMC4050161.pdf
"The main functions reported for the TSR1 domain include regulation of cell–cell and  *Correspondence to: Zhongjun Zhou; Email: zhongjun@hku.hk Submitted: 02/16/2014; Accepted: 03/10/2014; Published Online: 03/17/2014http://dx.doi.org/10.4161/cc.28494Distinct spatiotemporal expression of ISM1    during mouse and chick development Liliana os ório†, Xuewei Wu†, and Zhongjun Zhou* Department of Biochemistry; Li Ka Shing Faculty of Medicine; th e University of Hong Kong; Hong Kong, China; Shenzhen Institute of Research and Innovation; th e University  of Hong Kong; Shenzhen, China †th ese authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
"ISM1 protein sequence analysisThe complete amino acid sequence of ISM1 from human ( H.  sapiens , NP_543016.1), mouse ( M. musculus , NP_001263418.1),  chick (G. gallus , XP_415036.4), zebrafish ( D. ranio ,  NM_001012376.1), anole ( A. carolinensis , XM_003215294.1),  turtle ( C. pitca bellii , XP_005287456.1), and frog ( X. laevis ,  NP_001082228.1) were aligned using Clutal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo).",OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Other bioin - formatics analysis of the mouse ISM1 protein included identifi - cation of its signal peptide using SignalIP3.0 (http://www.cbs.dtu.dk/services/SignalP -3.0/) ant of its putative N -glycosylation  sites using NetNGly1.0 (http://www.cbs.dtu.dk/services/NetNGlyc/).,Non-OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Mech Dev 2002; 116:169-72; PMID:12128218 ; http://dx.doi.org/10.1016/ S0925-4773(02)00123-5 2.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Curr Biol 2005; 15:489-500; PMID :15797017 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Dev Biol 2007; 304:525-40; PMID:17306247 ;  http://dx.doi.org/10.1016/j.ydbio.2007.01.012 4.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
J Cell Biol 1986; 103:1635-48; PMID:2430973 ; http://dx.doi.org/10.1083/ jcb.103.5.1635 6.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Int J Biochem Cell Biol 2004; 36:969-74; PMID:15094110 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Trends Biochem Sci 2002; 27:113-5; PMID:11893501 ;  http://dx.doi.org/10.1016/S0968-0004(01)02049-78.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Cell Death Dis 2011; 2:e153-10 ;  PMID:21544092 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Bioinformatics 2009; 25:1189-91; PMID :19151095 ;  http://dx.doi.org/10.1093/bioinformatics/btp033 11.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
J Mol Biol 2004; 340:783-95; PMID:15223320 ;  http://dx.doi.org/10.1016/j.jmb.2004.05.028 12.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Dev Biol 2010; 346:25-38; PMID:20637190 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Development 2010; 137:2863-74; PMID:20667916 ;  http://dx.doi.org/10.1242/dev.05346214.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Front Neuroanat 2013; 7:18; PMID:23805080 ;  http://dx.doi.org/10.3389/fnana.2013.00018 16.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Wiley Interdiscip Rev Dev Biol 2013; 2:149-64; PMID:23799634 ; http://dx.doi.org/10.1002/ wdev.65 17.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Gene 2004; 335:101-8; PMID:15194193 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Curr Opin Genet Dev 2009; 19:444-53; PMID:19762225 ;  http://dx.doi.org/10.1016/j.gde.2009.08.001 19.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
Nature 2010; 468:214-22; PMID:21068830 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/64/cc-13-1571.PMC4050162.pdf
"In this paper, we sought out a model system that features:  (1) an ability to synchronously induce an RFB; (2) a single and  *Correspondence to: Geneviève Almouzni; Email: genevieve.almouzni@curie.fr Submitted: 11/19/2013; Revised: 03/18/2014; Accepted: 03/23/2014; Published Online: 03/25/2014http://dx.doi.org/10.4161/cc.28627Establishment of a replication fork barrier  following induction of DNA binding   in mammalian cells paolo Beuzer, Jean- pierre Quivy, and Geneviève Almouzni* Institut Curie; Centre de Recherche; p aris, France; CNRS; UMR3664; p aris, France; e quipe Labellisée Ligue contre le Cancer; UMR3664; p aris, France; U pMC; UMR3664; p aris,  France; Sorbonne University; p SL; p aris, France Keywords:  LacO-LacI, TetO-TetR, replication fork block, DNA replication, DNA damage repair, genome instability.",Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Cell 2011; 144:27-40; PMID:21215367 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nature 2012; 481:287-94; PMID:22258607 ; http://dx.doi.org/10.1038/ nature10760 4.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nat Rev Mol Cell Biol  2010; 11:208-19;  PMID:20177396 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nature 2000;  404:37-41;  PMID:10716434 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Mol Cell 2010;  40:179-204;  PMID:20965415 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Cell 2007; 128:721-33; PMID:17320509 ;  http://dx.doi.org/10.1016/j.cell.2007.01.030 8.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Mol Cell 2010; 37:736- 43; PMID:20227376 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nat Rev Mol Cell Biol  2010; 11:683-7;  PMID:20842177 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nat Cell Biol 2007; 9:675-82; PMID:17486118 ; http://dx.doi.org/10.1038/ncb159111.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
EMBO J 2002; 21:3201-11; PMID:12065432 ;  http://dx.doi.org/10.1093/emboj/cdf310 12.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Mol Cell 2000; 5:617-27; PMID:10882098 ;  http://dx.doi.org/10.1016/S1097-2765(00)80241-5 13.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Cell  1988; 55:637-43;  PMID:3052854 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Biochimie 2005; 87:591-602; PMID:15989976 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
J Biol Chem  1996; 271:33009-17;  PMID:8955146 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Curr Opin Virol  2012; 2:733-9;  PMID :23031715 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
J Cancer Res Clin Oncol 2006; 132:1-8; PMID:16180023 ; http://dx.doi.org/10.1007/ s00432-005-0036-x 20.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nucleic Acids Res 2009; 37:1713-25; PMID:19190094 ; http://dx.doi.org/10.1093/nar/ gkp02621.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nat Rev Genet 2012;  13:770-80;  PMID:23032257 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nat Genet 2001; 27:113-6;  PMID:11138010 ; http://dx.doi.org/10.1038/83673 23.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
EMBO J 2005; 24:1267- 76; PMID:15775982 ; http://dx.doi.org/10.1038/ sj.emboj.7600602 24.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Genes Dev 2003; 17:1497-506; PMID:12783853 ; http://dx.doi.org/10.1101/ gad.1085403 25.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nature 2011; 469:112- 5; PMID:21151105 ; http://dx.doi.org/10.1038/ nature09608 26.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Curr Opin Struct Biol  2006; 16:351-8;  PMID:16713248 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Semin Cell Dev Biol  2011; 22:866-74;  PMID:22020070 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Biochem J  2012; 443:13-26;  PMID:22417748 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nat Rev Mol Cell Biol 2012 ; 13:153-67;  PMID:22358331 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Mol Cell 2011; 43:122- 31; PMID :21726815 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nat Cell Biol 2001; 3:767-70; PMID:11483964 ;  http://dx.doi.org/10.1038/35087089 32.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
J Cell Biol 2011; 194:229-43;  PMID:21768289 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Science 2008; 320:1507-10;  PMID:18483401 ;  http://dx.doi.org/10.1126/science.1159051 34.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nucleic Acids Res 2012; 40:11363-79;  PMID:23034801 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Mol Biol Cell  2009; 20:2070-82;  PMID:19211845 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nucleic Acids Res 2006; 34:5194- 202; PMID:17000639 ; http://dx.doi.org/10.1093/ nar/gkl682 37.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
EMBO J  2006; 25:2596-604;  PMID:16724111 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nucleic Acids Res 2011; 39:6568-84; PMID :21576223 ;  http://dx.doi.org/10.1093/nar/gkr340 40.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
J Cell Biol 1999; 146:905-16; PMID:10477747 ; http://dx.doi.org/10.1083/ jcb.146.5.905 41.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Genes Dev 2011; 25:1320-7; PMID:21685366 ;  http://dx.doi.org/10.1101/gad.2053211 42.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Eur J Biochem 1997;  250:794-9;  PMID:9461304 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Cell Cycle 2008; 7:2809-12; PMID :18769153 ; http://dx.doi.org/10.4161/ cc.7.18.6689 44.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Cell 2010; 141:243-54; PMID:20362325 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
J Cell Sci 2012; 125:3529-34;  PMID:22553214 ; http://dx.doi.org/10.1242/ jcs.105353 46.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nature 2008; 456:529-33;  PMID:18931658 ;  http://dx.doi.org/10.1038/nature07476 ; http:// dx.doi.org/10.1038/nature07476 47.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
J Cell Biol 2011; 193:97-108;  PMID:21444690 ; http://dx.doi.org/10.1083/ jcb.201011083 48.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nat Cell Biol  2011; 13:243-53;  PMID:21317883 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nature 2008; 456:524-8;  PMID:18931659 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
DNA Repair (Amst) 2010; 9:1112-6; PMID:20724228 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
J Cell Sci 2002; 115:4037-51; PMID:12356909 ;  http://dx.doi.org/10.1242/jcs.00087 52.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nat Protoc 2011; 6:870-95;  PMID:21637205 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
EMBO Rep 2011; 12:1032-8; PMID:21836640 ;  http://dx.doi.org/10.1038/embor.2011.158 54.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Semin Cell Dev Biol 2011; 22:906-12; PMID:21782962 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Chromosoma 2004; 112:389- 97; PMID :15156327 ; http://dx.doi.org/10.1007/ s00412-004-0284-6 56.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Genes Cells  1996; 1:465-74;  PMID:9078378 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Microbiol Mol Biol Rev  2007; 71:13-35;  PMID:17347517 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
EMBO J 2003; 22:3431-40; PMID:12840005 ;  http://dx.doi.org/10.1093/emboj/cdg330 60.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Genes Dev 2001; 15:2060-8;  PMID :11511538 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Genetics 2008; 180:27-39; PMID:18723894 ; http://dx.doi.org/10.1534/ genetics.108.089243 62.,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Mol Cell Biol  2004; 24:9813-22;  PMID:15509785 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Mol Cell 2012; 46:722-34;  PMID:22749398 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Trends Cell Biol 2009; 19:29-41; PMID:19027300 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nucleic Acids Res 2012;  40:1485-98;  PMID:22021381 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Trends Genet 2012; 28:118-27;  PMID:22226176 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Cell  2004; 116:683-98;  PMID :15006351 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
J Cell Biol 1998; 143:563- 75; PMID:9813080 ; http://dx.doi.org/10.1083/ jcb.143.3.563 70.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
Nat Cell Biol 2001; 3:114-20; PMID:11175742 ;  http://dx.doi.org/10.1038/35055010 71.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
J Cell Biol  2004; 166:493-505;  PMID:15302854 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
EMBO J 2011; 30:480- 93; PMID:21179005 ; http://dx.doi.org/10.1038/ emboj.2010.335,Non-OADS,/arxiv_data1/oa_pdf/83/22/cc-13-1607.PMC4050166.pdf
"The rate of FMR1 gray zone expansions in the general population is variable, but large population studies report rates of 0.8% to 3.0% for repeat sizes between 41 and 54.19,20,22However, many of theFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"of PatientsLocation Gray Zone Rate (%) Rousseau et al.5635–54 Not reported Women 10,624 Canada 0.4 Dawson et al.5740–59 Newborns Men and women2,000 Spain 2.7 Zhong et al.5841–54 Not reported Men 56 USA 1.7 Spence et al.5940–59 (Pregnant women of advanced maternal age)Women 745 USA 2.2 Drasinover et al.5250–55 Not reported Women 10,587 Israel 0.5 Dombrowski et al.6040–54 Not reported Men 10,572 Canada 0.3 Penagarikano et al.2241–54 Not reported Men 158 Spain 3.2 Cronister et al.6145–54 Not reported Women 29,103 USA 0.7 Tzeng et al.6245–54 Newborns Boys 10,046 Taiwan 0.7 Metcalfe et al.6345–54 .18 years Women 338 Australia 0.7 Levesque et al.6445–54 Mother-newborn pairs Women, boys, and girls24,449 Canada 1.2 Fernandez-Carvajal et al.1445–54 Newborns Boys and girls5,267 Spain 3.8 Otsuka et al.6540–50 Not reported Men and women946 Japan 0.6 Tassone et al.1945–54 Newborns Boys and girls14,207 USA 1.2 Seltzer et al.6645–54 67–68 years Men and women6,747 USA 2.6Hall DA Gray Zone in the Fragile X Gene Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
49Gray Zone in the Fragile X Gene Hall DA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
Am J MedHall DA Gray Zone in the Fragile X Gene Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Genet 1999;83:322–325, doi: http://dx.doi.org/10.1002/(SICI)1096- 8628(19990402)83:4 ,322::AID-AJMG17 .3.0.CO;2-B.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Intention tremor, parkinsonism, and generalized brain atrophy in older male carriers of fragile X. Neurology 2001;57:127–130, doi: http://dx.doi.org/10.1212/WNL.57.1.127.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Hum Genet 2003;72:869–878, doi: http://dx.doi.org/10.1086/374321.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Clin Genet 2003;64: 54–56, doi: http://dx.doi.org/10.1034/j.1399-0004.2003.00089.x.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Hum Genet 2004;74:1051–1056, doi: http://dx.doi.org/10.1086/420700.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Clin Genet 2012;82:88–92, doi: http://dx.doi.org/10.1111/j.1399-0004.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Mov Disord 2010;25:1523–1524, doi: http://dx.doi.org/10.1002/mds.23150.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Transl Neurodegen 2013;2:10, doi: http://dx.doi.org/ 10.1186/2047-9158-2-10.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Neuropsychology 2008;22:48–60, doi: http://dx.doi.org/10.1037/ 0894-4105.22.1.48.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Eur J Hum Genet 2004;12:333–336, doi: http://dx.doi.org/10.1038/sj.ejhg.5201154.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Clin Genet 2005;68:471–473, doi: http://dx.doi.org/10.1111/j.1399-0004.2005.00514.x.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"J Mol Diagn 2009;11:324–329, doi: http://dx.doi.org/10.2353/jmoldx.2009.080173.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Hum Genet 1996;64:196–197, doi: http://dx.doi.org/10.1002/ (SICI)1096-8628(19960712)64:1 ,196::AID-AJMG35 .3.0.CO;2-G. 16.Coffee B, Keith K, Albizua I, et al.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Hum Genet 2009;85:503– 514, doi: http://dx.doi.org/10.1016/j.ajhg.2009.09.007.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Prenatal diagnosis 2000;20:611–614, doi: http://dx.doi.org/10.1002/1097-0223(200008)20:8 ,611::AID-PD881 .3.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Genome Med 2012;4:100, doi: http://dx.doi.org/10.1186/gm401.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"J Med Genet 2008;45: 498–499, doi: http://dx.doi.org/10.1136/jmg.2008.059055.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Med Genet A 2004;128A:250–255, doi: http://dx.doi.org/10.1002/ajmg.a.30116.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Genet Med 2005;7:584–587, doi: http://dx.doi.org/10.1097/ 01.GIM.0000182468.22666.dd.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Genet Med 2001;3:200–205, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Genet Med 2008;10:845–847, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"J Med Genet 2000;37:415–421, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Hum Genet 1999;64:495–507, doi: http://dx.doi.org/10.1086/302260.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Hum Repro 2006;21:952–957, doi: http://dx.doi.org/10.1093/humrep/dei432.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Hum Genet 2005;117:376–382, doi: http://dx.doi.org/10.1007/ s00439-005-1326-8.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease.Parkinsonism Relat Disord 2009;15:156–159, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Arch Neurol 2007;64:1002, doi: http:// dx.doi.org/10.1001/archneur.64.7.1002.Gray Zone in the Fragile X Gene Hall DA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Arch Neurol 2009;66:244–249, doi: http://dx.doi.org/10.1001/archneurol.2008.548.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Parkinsonism Relat Disord 2011;17:281–284, doi: http://dx.doi.org/10.1016/j.parkreldis.2010.12.013.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Arch Neurol 2009;66:244–249, doi: http://dx.doi.org/10.1001/archneurol.2008.548.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Neurogenetics 2005;6:51–52, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Mov Disord 2005;20:230–233, doi: http://dx.doi.org/10.1002/ mds.20297.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Neuroepidemiology 2006;26:151–155, doi: http://dx.doi.org/10.1159/000091656.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"40.Chonchaiya W, Agustini U, Pereira G, Tassone F, Hessl D, Hagerman R. Broad clinical involvement in a family affected by the fragile X premutation.Develop Behav Peds 2009;30:544–551, doi: http://dx.doi.org/10.1097/DBP.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Clin Genet 2013;84:74–77, doi: http://dx.doi.org/10.1111/cge.12026.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Arch Neurol 2004;61:1224–1229, doi: http://dx.doi.org/10.1001/archneur.61.8.1224.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"J Med Genet 2007;44:200–204, doi: http://dx.doi.org/10.1136/jmg.2006.043950.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Hum Genet 2000;66:6–15, doi: http://dx.doi.org/10.1086/302720.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Neurology 2006;67:1426–1431, doi: http://dx.doi.org/10.1212/01.wnl.0000239837.57475.3a.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Arch Neurol 2008;65:495– 498, doi: http://dx.doi.org/10.1001/archneur.65.4.495.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Med Genet B 2011;156B:502–506, doi: http://dx.doi.org/10.1002/ajmg.b.31189.49.Brunberg JA, Jacquemont S, Hagerman RJ, et al.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Genet Med 2011;13:392–399, doi: http://dx.doi.org/10.1097/GIM.0b013e3182064362.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome.Genet Med 2012;14:729–736, doi: http://dx.doi.org/10.1038/gim.2012.34.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Med Genet 2000;93:155–157, doi: http://dx.doi.org/ 10.1002/1096-8628(20000717)93:2 ,155::AID-AJMG13 .3.0.CO;2-G. 53.Sherman SL, Maddalena A, Howard-Peebles PN, et al.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Med Genet 1994;51:503–506, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"J Genet Couns 2012;21:752–760, doi: http://dx.doi.org/10.1007/s10897-012-9524-8.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Med Genet A 2013;161A:771– 778, doi: http://dx.doi.org/10.1002/ajmg.a.35833.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Biochem Mol Med 1995;56:63–69, doi: http://dx.doi.org/10.1006/ bmme.1995.1057.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Med Genet 1996;64:261–265, doi: http://dx.doi.org/10.1002/(SICI)1096- 8628(19960809)64:2 ,261::AID-AJMG5 .3.0.CO;2-X.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Med Genet 1996;64:181–183, doi: http://dx.doi.org/ 10.1002/(SICI)1096-8628(19960712)64:1 ,181::AID-AJMG31 .3.0.CO;2-H. 60.Dombrowski CLS, Morel ML, Rouillard P, Morgan K, Rousseau F. Premutation and intermediate-size FMR1 alleles in 10,572 males from the general population: Loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Hum Mol Genet 2002;11:371–378, doi: http://dx.doi.org/10.1093/hmg/11.4.371.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"61.Cronister A, DiMaio M, Mahoney MJ, Donnenfeld AE, Hallam S. Fragile X syndrome carrier screening in the prenatal genetic counseling setting.Genet Med 2005;7:246–250, doi: http://dx.doi.org/10.1097/01.GIM.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis ofHall DA Gray Zone in the Fragile X Gene Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Med Genet A 2005;133A:37–43, doi: http://dx.doi.org/10.1002/ajmg.a.30528.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Genet Med 2008;10:525–535, doi: http://dx.doi.org/10.1097/GIM.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Clin Genet 2009;76:511–523, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Brain Dev 2010;32:110– 114, doi: http://dx.doi.org/10.1016/j.braindev.2008.12.015.",OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
"Am J Med Genet B , 2012;159B:589–597, doi: http://dx.doi.org/10.1002/ajmg.b.32065.Gray Zone in the Fragile X Gene Hall DA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/df/af/tre-04-208-5194-1.PMC4050171.pdf
While patientneeds related to the motor and non-motor symptoms of MDs areFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"16Participants were asked to provide objective information on their number of hoursworked, number of hours missed from work due to health problems,and were also asked to rate how much health problems affected workproductivity as well as other regular daily activities on a scale ranging from 0 ( Health problems had no effect on my work/my daily activities )t o1 0 (Health problems completely prevented me from working/doing my daily activities ).Lageman SK, Cash TV, Mickens MN Non-motor Needs and Quality of Life in ET and PD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Table 1.Sample Characteristics Sample Characteristic PD ( N577) ET ( N519) Mean age (SD) 66.7 (9.0) 72.0 (13.4) (Range) (41–87) (47–93)Gender (%) Male 54.5 36.8 Female 45.5 63.2 Race/ethnicity (%) Caucasian 96.1 100.0 Native American 2.6 0.0Hispanic/Latino 1.3 0.0Pacific islander 0.0 5.3 Educational level (%) GED 1.3 0.0High school graduate 7.8 10.5 Vocational training or associate’s degree 20.8 21.1 Bachelor’s degree 36.4 47.4Master’s degree 22.1 15.8 Professional/doctoral degree 11.7 5.3 Employment status (%) Retired 58.4 63.2 Full time 15.6 15.8 Part time 10.4 5.3On disability 11.7 0.0 Unemployed, but not retired or on disability 3.9 5.3 Household income (%) Less than $25,000 9.1 10.5 $25,000–45,000 20.8 15.8 $45,001–65,000 14.3 10.5$65,001–85,000 10.4 21.1$85,001–105,000 16.9 10.5 Greater than $105,001 13.0 10.5 Prefer not to answer 15.6 21.1 Insurance holder (%) Self 72.7 63.2Non-motor Needs and Quality of Life in ET and PD Lageman SK, Cash TV, Mickens MN Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"1All responses were self-reported.Lageman SK, Cash TV, Mickens MN Non-motor Needs and Quality of Life in ET and PD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Table 2.Needs and Barriers to Care Assessment for Individuals with PD or ET Patient Need PD Patients ( N577) ET Patients ( N519) Endorsed Need (%) Endorsed Need (%) Symptom management 67.5 52.6 Tremor/gait/balance problems 50.6 31.6Speech/communication problems 40.3 5.3 Common medication side effects 28.6 21.1 Issues with swallowing 22.1 0Incontinence 23.4 0Sexual problems 15.6 0 Vision changes/issues 18.2 0 Communicating with treating doctors 13.0 10.5 Planning for the future 59.7 21.1 Long-term care planning 42.9 5.3 Financial concerns 36.4 5.3Resource identification and accessing resources 27.3 15.8 Legal issues 18.2 0.0 Wellness strategies 54.5 26.3 Beginning an exercise regime or adapting one to fit personal needs44.2 21.1 Nutritional changes and healthy eating strategies 36.4 15.8 Spirituality 13.0 15.8 Lifestyle changes 54.5 15.8 Driving 39.0 5.3 Vacationing and travel tips 35.1 10.5 Fall prevention 32.5 5.3Safety in the home 31.2 5.3 Thinking changes 50.6 15.8 Expressing self 40.3 10.5Memory 37.7 10.5 Attention 26.0 5.3 Problem solving 19.5 0.0 Stress management 31.2 36.8 Relationship changes 29.9 5.3 Maintaining a social life 22.1 5.3Non-motor Needs and Quality of Life in ET and PD Lageman SK, Cash TV, Mickens MN Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Table 2.Continued Changes in personal relationships post diagnosis 11.7 0.0 Identifying emotional support systems 13.0 5.3 Role changes 6.5 0.0 Parenting-related issues 0.0 0.0 Emotional changes 29.9 10.5 Experiencing anxiety, depression and apathy 24.7 10.5 Work-related issues 23.4 21.1 Disclosing your diagnosis: how to and if you should 10.4 15.8 Balancing family, medical and health responsibilities with work duties10.4 10.5 Transitioning from FT to PT work 7.8 0.0 Analyzing transferable skills and new/different job possibilities3.9 5.3 Advocating for accommodations 3.9 0.0 Caregiver stress 26.0 5.3 Personality/behavioral changes 20.8 0.0 Visual hallucinations 7.8 0.0Inappropriate behaviors 3.9 0.0 Aggression 2.6 0.0 Patient education about diagnosis 19.5 5.3Adjustment to diagnosis 15.6 10.5 Early onset diagnosis 13.0 5.3 Other 2.6 0.0Barriers to Care PD Patients ( N577) ET Patients ( N519) Endorsed Need (%) Endorsed Need (%) Cost of service 27.3 10.5Insurance does not cover cost of service 18.2 15.8 Service/specialist not available in local area 14.3 5.3 Balancing family, work and medical issues 13.0 26.3Stigma associated with having a movement disorder 7.8 31.6 Limited transportation 7.8 0.0 Lack of coordinated care 13.0 5.3Limited support from family 7.8 5.3 ET, Essential Tremor; FT, Full Time; PD, Parkinson’s Disease; PT, Part Time.Lageman SK, Cash TV, Mickens MN Non-motor Needs and Quality of Life in ET and PD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Over a quarter of our participants endorsed financial andNon-motor Needs and Quality of Life in ET and PD Lageman SK, Cash TV, Mickens MN Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"For every additional NMS reported, participants’ health-related QOL negatively increased by nearly 2 and 3 additional points, for PD and ET respectively.Interestingly, a relationship between NMS and emotional well-beingTable 3.Patient-ranked Services of Greatest Need Service Individuals with PD Individuals with ET Ranked Service as ‘‘Greatest’’ Need (%)Ranked Service as ‘‘Greatest’’ Need (%) Neurology 20.8 15.8 Exercise groups 18.2 5.3 Support group 10.4 31.6Physical therapy 13.0 5.3 Speech/language therapy 9.1 0.0 Sleep specialist 2.6 0.0Pharmacy 2.6 0.0 Clinical trials/research 1.3 5.3 Online/video support groups 1.3 5.3Nutritionist 1.3 0.0 Service Individuals with PD Individuals with ET Currently Receiving Service (%) Currently Receiving Service (%) Neurology 72.7 31.6 Pharmacy 31.2 36.8 Physical therapy 29.9 5.3Sleep specialist 10.4 0.0 Psychology 9.1 5.3 Speech/language therapy 6.5 0.0Counseling 6.5 15.8Nutrition 3.9 0.0 Neuropsychology 3.9 0.0 Occupational therapy 2.6 0.0Genetic counseling 1.3 0.0 Social work 0.0 0.0 ET, Essential Tremor; PD, Parkinson’s Disease.Lageman SK, Cash TV, Mickens MN Non-motor Needs and Quality of Life in ET and PD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"( N520)1.2 (2.1) 2.0 (3.5)Non-motor Needs and Quality of Life in ET and PD Lageman SK, Cash TV, Mickens MN Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"( N599)3.8 (2.5) 2.4 (2.4) LASA, Linear Analog Scale Assessment; MD, Movement Disorders; PDQ-39, Parkinson’s Disease-39; PD-NMS, Parkinson’s Disease Non-Motor Symptom Questionnaire; SD, Standard Deviation.Lageman SK, Cash TV, Mickens MN Non-motor Needs and Quality of Life in ET and PD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services10",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"References 1.Bermejo-Pareja F, Puertas-Martı ´n V. Cognitive features of essential tremor: A review of the clinical aspects and possible mechanistic underpinnings.Tremor Other Hyperkinet Mov 2012;2:http://tremorjournal.org/article/view/74.",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Parkinsonism Relat Disord 2012;18:407–413, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Acta Neurol Scand 2012;125:332–337, doi: http://dx.doi.org/10.1111/j.1600-0404.2011.01573.x.",OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Mov Disord 2010;25:704–709, doi: http://dx.doi.org/10.1002/mds.22868.",OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Mov Disord 2011;26: 399–406, doi: http://dx.doi.org/10.1002/mds.23462.",OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Mov Disord 2008; 23:1428–1434, doi: http://dx.doi.org/10.1002/mds.21667.",OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Mov Disord 2009;24:1641–1649, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Parkinsonism Relat Disord 2011;17:717–723, doi: http://dx.doi.org/10.1016/j.parkreldis.2011.02.018.",OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Parkinsonism Relat Disord 2014;20:17–21, doi: http://dx.doi.org/10.1016/j.parkreldis.2013.09.004.12.Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG.",OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"J Biomed Inform 2009;42:377–381, doi: http://dx.doi.org/10.1016/j.jbi.2008.08.",OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Mov Disord 2006;21:916–923, doi: http://dx.doi.org/10.1002/mds.20844.",OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Age Ageing 1997;26:353–357, doi: http://dx.doi.org/10.1093/ageing/26.5.353.",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"J Pain Symptom Manage 2007;34:628–638, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Pharmacoeconomics 1993;4: 353–365, doi: http://dx.doi.org/10.2165/00019053-199304050-00006.",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Mov Disord 2011;26(Suppl 3):S42–S80, doi: http://dx.doi.org/10.1002/mds.23884.",OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Mov Disord 2008;23:183–189, doi: http://dx.doi.org/10.1002/mds.21803.",OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Alzheimer Dis Assoc Disord 2002;16:261–269, doi: http://dx.doi.org/10.1097/00002093-200210000-00008.",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Gerontologist 2004;44:836–843, doi: http://dx.doi.org/10.1093/ geront/44.6.836.",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"Health Qual Life Outcomes 2014;12:11, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"1186/1477-7525-12-11.Non-motor Needs and Quality of Life in ET and PD Lageman SK, Cash TV, Mickens MN Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services11",Non-OADS,/arxiv_data1/oa_pdf/ee/69/tre-04-240-5569-1.PMC4050172.pdf
"6,7There are, however, a small subset of patients in whom we have observed thatmanagement utilizing STN DBS has resulted in either troublesomeFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
Brittle Diskenesia after DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
Brittle Diskenesia after DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Move Disord 11992;7:117–124, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Move Disord 1994;9:2–12, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"N Engl J Med 2000; 342:1484–1491, doi: http://dx.doi.org/10.1056/NEJM200005183422004.",OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Move Disord 2008;23(S3):S599–S612, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson’s disease.Move Disord 2010;25:858–866, doi: http://dx.doi.org/10.1002/mds.22890.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Parkinsonism Relat Disord 2005;11:449–452, doi: http://dx.doi.org/10.1016/j.parkreldis.2005.05.008.",OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Move Disord 2003;18:1250–1256, doi: http://dx.doi.org/10.1002/ mds.10527.",OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Neurology 1991;41(Pt 1):202–205, doi: http://dx.doi.org/ 10.1212/WNL.41.2_Part_1.202.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Int Rev Neurobiol 2011;98:31–54, doi: http://dx.doi.org/10.1016/B978-0-12-381328-2.00002-X.",OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Stereotact Funct Neurosurg 2010;88: 29–34, doi: http://dx.doi.org/10.1159/000260077.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Eur Neurol 2009;61:94–99, doi: http://dx.doi.org/10.1159/ 000177941.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"J Neurol Neurosurg Psychiatry 2006;77:172–174, doi: http://dx.doi.org/10.1136/ jnnp.2005.068940.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"N Engl J Med 2006;355:896–908, doi: http://dx.doi.org/10.1056/NEJMoa060281.",OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"N Engl J Med 2010;362:2077–2091, doi: http://dx.doi.org/10.1056/NEJMoa0907083.",OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Lancet Neurol 2012;11:140–149, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Neurology 2012; 79:55–65, doi: http://dx.doi.org/10.1212/WNL.0b013e31825dcdc1.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Acta Neurochir Suppl 2006;99:33–35, doi: http://dx.doi.org/10.1007/978-3-211-35205-2_6.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"J Neurosurg 2002;97:1152–1166, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"J Neurol Neurosurg Psychiatry 2009;80:979–985, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
"Arch Neurol 1992;49:1123–1130, doi: http://dx.doi.org/10.1001/archneur.1992.00530350037016.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
Brittle Diskenesia after DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/6d/6f/tre-04-242-5565-1.PMC4050173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/e1/main.PMC4050180.pdf
"In contrast, type I DGKs are relatively large for EF-hand pro- teins (80–90 kDa), and represent a fusion protein connected to EF- hand motifs (approximately 110 kDa) that are combined with http://dx.doi.org/10.1016/j.fob.2014.04.003 2211-5463/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/c6/e1/main.PMC4050180.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: C1Ds, C1 domains; CR, catalytic region; DG, diacylglycerol; DGK, diacylglycerol kinase; EFHs, EF-hand motifs; EGFP, enhanced green ﬂuorescenceprotein; EGTA, ethylene glycol tetraacetic acid; GST, glutathione S-transferase; RVH, recoverin homology; RVHD, RVH domain; TF, trigger factor ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/c6/e1/main.PMC4050180.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.04.003 .",OADS,/arxiv_data1/oa_pdf/c6/e1/main.PMC4050180.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/ec/main.PMC4050181.pdf
SND1 http://dx.doi.org/10.1016/j.fob.2014.03.012 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/18/ec/main.PMC4050181.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ACE, angiotensin-I converting enzyme; ACE-I, ACE inhibitors; AT1R, angiotensin II type 1 receptor; EMT, epithelial–mesenchymal transition; FDR,false discovery rate; HCC, human hepatocellular carcinoma; LP, losartan potassium;MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NASH, non-alcoholic steatohepatitis; PAI-1, plasminogen activator inhibitor-1; RISC, RNA- induced silencing complex; SND1, Staphylococcal nuclease domain containing-1 ⇑Corresponding author at: Department of Human and Molecular Genetics, Virginia Commonwealth University, 1220 East Broad St, PO Box 980035, Richmond,VA 23298, United States.",Non-OADS,/arxiv_data1/oa_pdf/18/ec/main.PMC4050181.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.03.012 .",OADS,/arxiv_data1/oa_pdf/18/ec/main.PMC4050181.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/fd/main.PMC4050182.pdf
"Ab40 and A b42 are the most common forms of A b, where the Ab42 peptide is more prone to aggregate and form soluble dimers, http://dx.doi.org/10.1016/j.fob.2014.04.006 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6a/fd/main.PMC4050182.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: APP, amyloid precursor protein; A b, amyloid- bpeptide; AICD, amyloid precursor protein intracellular domain; AD, Alzheimer disease; FAD, familial AD; TMD, transmembrane domains; PS, presenilin; NTF, N-terminal fragment; CTF, C-terminal fragment; ER, endoplasmic reticulum; Lep, leaderpeptidase; BD8, blastocyst-derived embryonic stem cells; GVP, Gal4VP16; GCB, c-secretase inhibitor coupled to biotin; WT, wild type; FLIM/FRET, Fluorescence Lifetime Imaging/ Fluorescence Resonance Energy Transfer; CHAPSO, 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acid; Bis-Tris, 2-(bis(2-hydroxyethyl)amino)-2-(hydroxymethyl)propane-1,3-diol; MSD,Meso Scale Discovery; RM, rough microsomes; CRM, column-washed dog pancreas rough microsomes; Endo H, endoglycosidase H; MGD, minimal glycosylation distance ⇑Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/6a/fd/main.PMC4050182.pdf
"We pre- dicted the DGappvalue for PS1 TMD1-9, including their ﬂanking residues of PS1 by a computational model provided by the DGpre- diction server ( http://www.cbr.su.se/DGpred/ ).",OADS,/arxiv_data1/oa_pdf/6a/fd/main.PMC4050182.pdf
#The predicted DGvalues were determined by the DGprediction server (http://www.cbr.su.se/DGpred/).J.,OADS,/arxiv_data1/oa_pdf/6a/fd/main.PMC4050182.pdf
⁄Mutations are from the Alzheimer Disease and Frontotemporal Dementia Mutation Database ( http://www.molgen.ua.ac.be/admutations/ ).,OADS,/arxiv_data1/oa_pdf/6a/fd/main.PMC4050182.pdf
#The predicted DGvalues were determined by the DGprediction server ( http://www.cbr.su.se/DGpred/ ).J.,OADS,/arxiv_data1/oa_pdf/6a/fd/main.PMC4050182.pdf
"Region Mutation Age of onset (years)*Ab42/A b40 ratio change from WT Membrane integration change from WT (%) TMD2 I143T 34.0 4.4 0 TMD3 L166P 24.0 7.3 /C02 TMD6 A246E 52.5 1.2 /C013 TMD6 L250S 52.2 1.7 /C043 H7 E280A 47.4 2.0 +16H7 P284L 32.0 1.9 +39HL6 Dexon9 45.5 3.2 0 TMD7 R377M 39 1.4 /C020 TMD7 G384A 34.9 6.0 +12 TMD7 F386S 37–58 [70] 2.6 /C047 TMD7 S390I 39–49 [71] 1.9 +23 TMD7 L392P 38.3 3.6 /C046 TMD7 L392V 42.5 2.3 /C021 *Mutations and data are from the Alzheimer Disease and Frontotemporal Dementia Mutation Database ( http://www.molgen.ua.ac.be/admutations/ ), except for the indicated publications.",Non-OADS,/arxiv_data1/oa_pdf/6a/fd/main.PMC4050182.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/74/main.PMC4050183.pdf
The highly http://dx.doi.org/10.1016/j.fob.2014.04.011 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/66/74/main.PMC4050183.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: MD, molecular dynamics; Sc, Saccharomyces cerevisiae ; Ub, ubiquitin; UBC, ubiquitin-binding domain ⇑Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/66/74/main.PMC4050183.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.04.011 .",OADS,/arxiv_data1/oa_pdf/66/74/main.PMC4050183.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/63/dc/main.PMC4050184.pdf
"Currently and due in part to a lack of understanding of viral pathogenesis of EV71 causing HFMD, there are no effective antivi- ral therapies or vaccines approved by the United States Food and http://dx.doi.org/10.1016/j.fob.2014.04.005 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/63/dc/main.PMC4050184.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: EV71, Enterovirus 71; HFMD, Hand, Foot and Mouth Disease; ISG, interferon stimulated genes; MOI, multiplicity of infection; RD, rhabdomyosarcoma ⇑Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/63/dc/main.PMC4050184.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.04.005 .",OADS,/arxiv_data1/oa_pdf/63/dc/main.PMC4050184.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/17/main.PMC4050185.pdf
This study was carried out in accordance with the Guideline for Animal http://dx.doi.org/10.1016/j.fob.2014.03.011 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/d9/17/main.PMC4050185.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/d9/17/main.PMC4050185.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/46/main.PMC4050186.pdf
This is http://dx.doi.org/10.1016/j.fob.2014.04.008 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/35/46/main.PMC4050186.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: b2GPI, beta2-glycoprotein-I; FRET, ﬂuorescence resonance energy transfer spectroscopy; FTIR, Fourier-transform infrared spectroscopy; HDL,high-density lipoproteins; ITC, isothermal titration calorimetry; LAL, Limulus amebocyte lysate; LBP, lipopolysaccharide-binding protein; LDL, low-density lipoproteins; LPS, lipopolysaccharides; MNC, mononuclear cells; PC, phosphatidyl-choline; PS, phosphatidylserine; SAXS, small-angle X-ray scattering ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/35/46/main.PMC4050186.pdf
The BamHI fragment containing the kanamycin resistance ( kanr) cassette from pJMK30 [14] was http://dx.doi.org/10.1016/j.fob.2014.04.012 2211-5463/ /C2112014 Federation of European Biochemical Societies.,OADS,/arxiv_data1/oa_pdf/bb/97/main.PMC4050187.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/bb/97/main.PMC4050187.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.04.012 .",OADS,/arxiv_data1/oa_pdf/bb/97/main.PMC4050187.pdf
Health Protection Agency (HPA) .http://www.hpa.org.uk/2011 .,Non-OADS,/arxiv_data1/oa_pdf/bb/97/main.PMC4050187.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/a1/main.PMC4050188.pdf
One variant lacks the ﬁrst 29 amino acids (hKSR2 DN29) and the second identiﬁed http://dx.doi.org/10.1016/j.fob.2014.04.004 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/a1/main.PMC4050188.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: KSR, kinase suppressor of Ras; ERK, extracellular signal-regulated protein kinase; T-KSR2, testes-kinase suppressor of Ras 2; MAPK, mitogen activated protein kinase; CA, conserved area; SH2, Src homology 2; RACE, rapid ampliﬁcationof cDNA ends; NDK-1, nucleoside diphosphate kinase 1 ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/c3/a1/main.PMC4050188.pdf
TGF bis a central contributor to hepatic ﬁbrosis and has been implicated to contribute to hepatocarcinogenesis through diverse http://dx.doi.org/10.1016/j.fob.2014.04.007 2211-5463/ /C2112014 Federation of European Biochemical Societies.,Non-OADS,/arxiv_data1/oa_pdf/7d/da/main.PMC4050189.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: EV, extracellular vesicle; HCC, hepatocellular carcinoma; miRNA, microRNA; VD, vesicle-depleted; lncRNA, long non-coding RNA; linc-ROR, longintergenic non-coding RNA; TGF b, transforming growth factor b; CT, cycle threshold; siRNA, small interfering RNA qFinancial support: Supported in part by Grants R01DK069370 and UH2TR000884 from the National Institutes of Health.",Non-OADS,/arxiv_data1/oa_pdf/7d/da/main.PMC4050189.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.04.007 .",OADS,/arxiv_data1/oa_pdf/7d/da/main.PMC4050189.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/e9/main.PMC4050191.pdf
"Currently at least ﬁve cen- trin-targets are known: XPC (xeroderma pigmentosum group C protein), which has 1 centrin-binding site and, is involved in DNA repair [9]; Sﬁ1 (suppressor of fermentation-induced loss of stress resistance protein 1), which is a helicoid protein, has 25 cen- trin-binding motifs and is involved in centrosome duplication and cellular division [10]; Sac3 which is involved in RNA transfer from http://dx.doi.org/10.1016/j.fob.2014.04.002 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/03/e9/main.PMC4050191.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: C-HsCen, C-terminal domain of centrin; CK2, casein protein kinase; HPLC, high pressure liquid chromatography; HsCen, human centrin; ITC,isothermal titration calorimetry; MALDI-TOF, matrix-assisted laser desorptionionization time of ﬂight; Sﬁ1, suppressor of fermentation-induced loss of stressresistance protein 1; Trd, transducin; XPC, xeroderma pigmentosum group C protein ⇑Corresponding author at: Institut Curie, Centre de Recherche, INSERM U759, 15 Rue Georges Clemenceau, Centre Universitaire d’Orsay, Bâtiment 112, F-91405Orsay Cédex, France.",Non-OADS,/arxiv_data1/oa_pdf/03/e9/main.PMC4050191.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.04.002 .",OADS,/arxiv_data1/oa_pdf/03/e9/main.PMC4050191.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/18/main.PMC4050192.pdf
MiRNA-binding and processing http://dx.doi.org/10.1016/j.fob.2014.04.010 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/f9/18/main.PMC4050192.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ActD, Actinomycin D; CRM1, chromosomal maintenance 1; LNA, locked nucleic acid; pre, precursor; qPCR, quantitative real-time PCR; Pol I, RNA polymerase I; rRNA, ribosomal RNA; siRNA, short interfering RNA; snoRNA, small nucleolar RNA ⇑Corresponding author at: Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, 1550 Orleans Street, CRB2, Room 444, Baltimore, MD 21287, USA.",Non-OADS,/arxiv_data1/oa_pdf/f9/18/main.PMC4050192.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.04.010 .",OADS,/arxiv_data1/oa_pdf/f9/18/main.PMC4050192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/8b/main.PMC4050193.pdf
http://dx.doi.org/10.1016/j.fob.2014.04.009 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/df/8b/main.PMC4050193.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: Dex, dexamethasone; GC, glucocorticoids; GR, glucocorticoid receptor; HEK293, human embryonic kidney cells; LPS, lipopolysaccharide; NF- jB, nuclear factor kappa B; TNF, tumor necrosis factor ⇑Corresponding author at: Laboratorio de Biología Molecular y Apoptosis, Instituto de Investigaciones Médicas Alfredo Lanari, IDIM-CONICET, Facultad deMedicina, Universidad de Buenos Aires, Combatientes de Malvinas 3150, C1427AROBuenos Aires, Argentina.",Non-OADS,/arxiv_data1/oa_pdf/df/8b/main.PMC4050193.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/c7/main.PMC4050194.pdf
"In contrast, other Authors claim that FBP is a genuine CraECeffector [4,13] and that the glycolytic ﬂux of http://dx.doi.org/10.1016/j.fob.2014.03.013 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/70/c7/main.PMC4050194.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: Cra, catabolic repression/activation protein; F1P, fructose-1- phosphate; FBP, fructose-1,6-bisphosphate; G6P, glucose 6-phosphate; F6P, fructose-6-phosphate; ITC, isothermal calorimetry ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/70/c7/main.PMC4050194.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.03.013 .",OADS,/arxiv_data1/oa_pdf/70/c7/main.PMC4050194.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/7d/main.PMC4050195.pdf
"Following the BCR stimulation by antigens, B cells migrate into the GC and rapidly proliferate within the GC microenvironment http://dx.doi.org/10.1016/j.fob.2014.04.001 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/43/7d/main.PMC4050195.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: Ag, antigen; BCR, B cell receptor; GC, germinal center; FDC, follicular dendritic cells; PC, plasma cells ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/43/7d/main.PMC4050195.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.04.001 .",OADS,/arxiv_data1/oa_pdf/43/7d/main.PMC4050195.pdf
"Journal of  Preventive Medicine  & Public Health 129 Copyright © 2014  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:129-135   •  http://dx.doi.org/10.3961/jpmph.2014.47.3.129 The Status and Future Challenges of Tobacco Control   Policy in Korea Hong-Jun Cho Department of Family Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaSpecial Article Tobacco use is the most important preventable risk factor for premature death.",Non-OADS,/arxiv_data1/oa_pdf/7e/5a/jpmph-47-129.PMC4050209.pdf
"Key words:  Tobacco, Korea, Smoke-free policy Received:  March 13, 2014; Accepted:  May 8, 2014 Corresponding author:  Hong-Jun Cho, MD, PhD 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-3812, Fax: +82-2-3010-3815 E-mail : hjcho@amc.seoul.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Tobacco use is the most important preventable risk factor  for premature mortality as it kills approximately 5 million peo - ple worldwide every year [1].",Non-OADS,/arxiv_data1/oa_pdf/7e/5a/jpmph-47-129.PMC4050209.pdf
Available from:  http://www.who.int/tobacco/global_report/2013/en/.,Non-OADS,/arxiv_data1/oa_pdf/7e/5a/jpmph-47-129.PMC4050209.pdf
Available from: http://www.who.int/me - diacentre/factsheets/fs339/en/.,OADS,/arxiv_data1/oa_pdf/7e/5a/jpmph-47-129.PMC4050209.pdf
Available from:  http://www.heartfoundation.org.au/SiteCollectionDocu - ments/Evidence-Paper-Plain-Packaging.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/5a/jpmph-47-129.PMC4050209.pdf
Available from: http://www.uknscc.org/uknscc2013_post - er_221.php.,Non-OADS,/arxiv_data1/oa_pdf/7e/5a/jpmph-47-129.PMC4050209.pdf
"Journal of  Preventive Medicine  & Public Health 136 Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:136-143   •  http://dx.doi.org/10.3961/jpmph.2014.47.3.136 Burden of Disease in Japan: Using National and   Subnational Data to Inform Local Health Policy Stuart Gilmour, Yi Liao, Ver Bilano, Kenji Shibuya  Department of Global Health Policy, Graduate School of Medicine, University of Tokyo, Tokyo, JapanSpecial Article The Global Burden of Disease (GBD) study has been instrumental in guiding global health policy development since the early 1990s.",Non-OADS,/arxiv_data1/oa_pdf/59/f8/jpmph-47-136.PMC4050210.pdf
"Key words:  Burden of disease, Japan, Comparative risk factor analysis, Health policy, Non-communicable disease, Aging Received:  May 2, 2014; Accepted:  May 19, 2014 Corresponding author:  Kenji Shibuya, PhD 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan Tel: +81-3-5841-3688, Fax: +81-3-5841-3637 E-mail : shibuyak@m.u-tokyo.ac.jp This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION The Global Burden of Disease (GBD) is a an essential tool in  the global battle to improve health [1].",Non-OADS,/arxiv_data1/oa_pdf/59/f8/jpmph-47-136.PMC4050210.pdf
Available from: http://www.healthdata.org/ gbd/about.,Non-OADS,/arxiv_data1/oa_pdf/59/f8/jpmph-47-136.PMC4050210.pdf
Available from: http://www.healthdata.,Non-OADS,/arxiv_data1/oa_pdf/59/f8/jpmph-47-136.PMC4050210.pdf
"Journal of  Preventive Medicine  & Public Health 144 Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:144-149   •  http://dx.doi.org/10.3961/jpmph.2014.47.3.144 Airborne Nicotine Concentrations in the Workplaces of  Tobacco Farmers Seok-Ju Yoo1, Sung-Jun Park1, Byoung-Seok Kim1, Kwan Lee1, Hyun-Sul Lim1, Jik-Su Kim2, In-Shik Kim3 1Department of Preventive Medicine, Dongguk University College of Medicine, Gyeongju; 2Jinbo Tobacco Growers Cooperative Association,   Cheongsong; 3Department of Health Promotion Center, Dong-A University Hospital, Busan,  Korea Original Article Objectives: Nicotine is a natural alkaloid and insecticide in tobacco leaves.",Non-OADS,/arxiv_data1/oa_pdf/6e/49/jpmph-47-144.PMC4050211.pdf
"Key words:  Nicotine, Inhalation, Poisoning, Green tobacco sickness Received:  March 17, 2014 Accepted:  April 4, 2014 Corresponding author:  Kwan Lee, MD, PhD  123 Dongdae-ro, Gyeongju 780-714, Korea Tel: +82-54-770-2408, Fax: +82-54-770-2438 E-mail : kwaniya@dongguk.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Nicotine is well known for its relationship with smoking,  secondhand smoke, and environmental tobacco smoke; how - ever, the fact that nicotine is a naturally alkaloid and insecti - cide in tobacco leaves is less widely discussed [1,2].",Non-OADS,/arxiv_data1/oa_pdf/6e/49/jpmph-47-144.PMC4050211.pdf
Available  from: http://ktgo.or.kr/04/07.asp (Korean).,Non-OADS,/arxiv_data1/oa_pdf/6e/49/jpmph-47-144.PMC4050211.pdf
Available  from: http://www.cdc.gov/niosh/nmam/pdfs/2551.pdf.,OADS,/arxiv_data1/oa_pdf/6e/49/jpmph-47-144.PMC4050211.pdf
"Journal of  Preventive Medicine  & Public Health 150 Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:150-157   •  http://dx.doi.org/10.3961/jpmph.2014.47.3.150 The Effect of Sleep Duration on the Risk of Unintentional  Injury in Korean Adults Yeon-Yong Kim1, Un-Na Kim1, Jin-Seok Lee1,2, Jong-Heon Park2 1Department of Health Policy and Management, Seoul National University College of Medicine, Seoul; 2Institute of Health Policy and Management,  Medical Research Center, Seoul National University, Seoul, KoreaOriginal Article Objectives: The decrease or increase in sleep duration has recently been recognized as a risk factor for several diseases, including hy - pertension and obesity.",Non-OADS,/arxiv_data1/oa_pdf/8c/e6/jpmph-47-150.PMC4050212.pdf
"Key words:  Sleep duration, Wounds and injuries, Community health survey Received:  October 16, 2013; Accepted:  April 25, 2014 Corresponding author:  Jong-Heon Park, MD, PhD 311 Dongmak-ro, Mapo-gu, Seoul 121-749, Korea Tel: +82-2-3270-9699, Fax: +82-2-3275-8024 E-mail : parkjh@nhis.or.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Approximately 20% of the adult population experiences pe - riods of decreased sleep duration [1].",Non-OADS,/arxiv_data1/oa_pdf/8c/e6/jpmph-47-150.PMC4050212.pdf
"Journal of  Preventive Medicine  & Public Health 158 Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:158-168   •  http://dx.doi.org/10.3961/jpmph.2014.47.3.158 Variation in Meal-skipping Rates of Korean Adolescents  According to Socio-economic Status: Results of the Korea  Youth Risk Behavior Web-based Survey Seri Hong1,2, Hong Chul Bae2,3, Hyun Soo Kim2,3, Eun-Cheol Park1-3 1Graduate School of Public Health, Yonsei University, Seoul; 2Institute of Health Services Research, Yonsei University, Seoul;   3Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, KoreaOriginal Article Objectives: To identify and evaluate the trend of meal-skipping rates among Korean adolescents with their contributing causes and  the influence of household income level on meal skipping.",Non-OADS,/arxiv_data1/oa_pdf/d3/ce/jpmph-47-158.PMC4050213.pdf
"Key words:  Meal skipping, Social class, Adolescent, Eating habits Received:  November 17, 2013; Accepted:  April 30, 2014 Corresponding author:  Eun-Cheol Park, MD, PhD  50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Tel: +82-2-2228-1862, Fax: +82-2-392-8133 E-mail : ecpark@yuhs.ac This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Nutrition and eating habits are important factors affecting  the health of a population.",Non-OADS,/arxiv_data1/oa_pdf/d3/ce/jpmph-47-158.PMC4050213.pdf
"Journal of  Preventive Medicine  & Public Health 169 Copyright © 2014  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:169-176   •  http://dx.doi.org/10.3961/jpmph.2014.47.3.169 Assessment of Occupational Symptoms and Chemical  Exposures for Nail Salon Technicians in Daegu City, Korea Sung-Ae Park1, Sugyeong Gwak2, Sangjun Choi1,2 1Department of Public Health, Graduate School, Catholic University of Daegu, Gyeongsan; 2Department of Occupational Health, Graduate School,  Catholic University of Daegu, Gyeongsan, KoreaOriginal Article Objectives: This study aimed to evaluate occupational symptoms and chemical exposures of nail salon technicians.",Non-OADS,/arxiv_data1/oa_pdf/2e/84/jpmph-47-169.PMC4050214.pdf
"Key words:  Nail salon, Nail technician, Occupational symptom, Methylmethacrylate Received:  March 2, 2014; Accepted:  May 16, 2014 Corresponding author:  Sangjun Choi, PhD 13-13 Hayang-ro, Hayang-eup, Gyeongsan 712-702, Korea Tel: +82-53-850-3738, Fax: +82-53-850-3736 E-mail : junilane2@cu.ac.kr  This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION The professional nail care business is growing rapidly since  being introduced in Korea from the US in the late 1990s.",Non-OADS,/arxiv_data1/oa_pdf/2e/84/jpmph-47-169.PMC4050214.pdf
Available from: http://www.knanail.or.kr  (Korean).,Non-OADS,/arxiv_data1/oa_pdf/2e/84/jpmph-47-169.PMC4050214.pdf
Available from: http://www.moel.go.kr/english/poli/ poliLaw_view.jsp?idx =264&tab =7.,Non-OADS,/arxiv_data1/oa_pdf/2e/84/jpmph-47-169.PMC4050214.pdf
Available  from: http://www.cassen.ca/files/sampling-instructions/3m- ovm-sampling.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2e/84/jpmph-47-169.PMC4050214.pdf
Available from: http://www.hse.gov.uk/research/rrp - df/rr647.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2e/84/jpmph-47-169.PMC4050214.pdf
Available from:  http://www.epa.gov/dfe/pubs/projects/salon/index.htm.,OADS,/arxiv_data1/oa_pdf/2e/84/jpmph-47-169.PMC4050214.pdf
Avail - able from: http://www.fda.gov/Cosmetics/ProductsIngredi -ents/Products/ucm127068.htm.,Non-OADS,/arxiv_data1/oa_pdf/2e/84/jpmph-47-169.PMC4050214.pdf
Available  from: http://www.hse.gov.uk/pubns/guidance/sr13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2e/84/jpmph-47-169.PMC4050214.pdf
"Journal of  Preventive Medicine  & Public Health 177 Copyright © 2014  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:177-181   •  http://dx.doi.org/10.3961/jpmph.2014.47.3.177 Epidemiological Investigation of an Outbreak of   Salmonellosis in Gyeongju, Korea Seok-Ju Yoo, Hyun-Sul Lim, Kwan Lee Department of Preventive Medicine, Dongguk University College of Medicine, Gyeongju, KoreaBrief Report Objectives: A salmonellosis outbreak occurred within a community of Gyeongju residents who ingested catered food from a wedding  in June 2009.",Non-OADS,/arxiv_data1/oa_pdf/8a/4f/jpmph-47-177.PMC4050215.pdf
"Key words:  Epidemiologic studies, Salmonella infections, Egg Received:  March 15, 2014; Accepted:  April 9, 2014 Corresponding author:  Hyun-Sul Lim, MD, PhD  123 Dongdae-ro, Gyeongju 780-714, Korea Tel: +82-54-770-2401, Fax: +82-54-770-2438 E-mail : wisewine@dongguk.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Salmonellosis is an etiologic term used to describe a various  conditions that affect humans and many animal species [1].",Non-OADS,/arxiv_data1/oa_pdf/8a/4f/jpmph-47-177.PMC4050215.pdf
"101 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 The digital version of JPIS offers more  than ever Tae-Il Kim Department of Periodontology, Seoul National University School of Dentistry, Seoul, Korea Editorial J Periodontal Implant Sci 2014;44:101-101 http://dx.doi.org/10.5051/jpis.2014.44.3.101 Received:  Jun.",Non-OADS,/arxiv_data1/oa_pdf/2c/84/jpis-44-101.PMC4050225.pdf
ORCID  Tae-Il Kim http://orcid.org/0000-0003-4087-8021 This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/84/jpis-44-101.PMC4050225.pdf
"102 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Long-term implant success at the  Academy for Oral Implantology:  8-year follow-up and risk factor  analysis Dieter Busenlechner, Rudolf Fürhauser, Robert Haas, Georg Watzek,   Georg Mailath, Bernhard Pommer* Academy for Oral Implantology, Vienna, Austria Research Article J Periodontal Implant Sci 2014;44:102-108 http://dx.doi.org/10.5051/jpis.2014.44.3.102 Purpose:  Rehabilitation of the incomplete dentition by means of osseointegrated dental  implants represents a highly predictable and widespread therapy; however, little is known  about potential risk factors that may impair long-term implant success.",Non-OADS,/arxiv_data1/oa_pdf/8e/f3/jpis-44-102.PMC4050226.pdf
This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8e/f3/jpis-44-102.PMC4050226.pdf
"http://dx.doi.org/10.5051/jpis.2014.44.3.102 www.jpis.org103A prerequisite for predictable implant osseointegration is a suffi - cient amount of bone volume and satisfactory quality of the bone  at the implant recipient site, both of which are frequently compro - mised when teeth are lost due to chronic inflammation or even  trauma.",Non-OADS,/arxiv_data1/oa_pdf/8e/f3/jpis-44-102.PMC4050226.pdf
Implant success at the Implant Academy http://dx.doi.org/10.5051/jpis.2014.44.3.102 www.jpis.org104tion (Fig.,Non-OADS,/arxiv_data1/oa_pdf/8e/f3/jpis-44-102.PMC4050226.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.102 www.jpis.org105tific literature.,Non-OADS,/arxiv_data1/oa_pdf/8e/f3/jpis-44-102.PMC4050226.pdf
Implant success at the Implant Academy http://dx.doi.org/10.5051/jpis.2014.44.3.102 www.jpis.org106of implant failure with an odds ratio of 2.25; we found a 3-fold  increased risk our patient sample.,Non-OADS,/arxiv_data1/oa_pdf/8e/f3/jpis-44-102.PMC4050226.pdf
"http://dx.doi.org/10.5051/jpis.2014.44.3.102 www.jpis.org107with a history of periodontitis compared to those without a history  of periodontitis [21], and we found a 2-fold increased failure risk  in our population.",Non-OADS,/arxiv_data1/oa_pdf/8e/f3/jpis-44-102.PMC4050226.pdf
ORCID Dieter Busenlechner http://orcid.org/0000-0002-6731-6160 Rudolf Fürhauser http://orcid.org/0000-0001-9373-2101 Robert Haas http://orcid.org/0000-0003-0989-5069 Georg Mailath http://orcid.org/0000-0001-8869-4059 Georg Watzek http://orcid.org/0000-0003-4998-2829Bernhard Pommer http://orcid.org/0000-0002-2617-0353   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/f3/jpis-44-102.PMC4050226.pdf
Implant success at the Implant Academy http://dx.doi.org/10.5051/jpis.2014.44.3.102 www.jpis.org108term dental implant success and survival: a clinical study after  an observation period up to 6 years.,Non-OADS,/arxiv_data1/oa_pdf/8e/f3/jpis-44-102.PMC4050226.pdf
"109 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Improvement in periodontal healing  after periodontal surgery supported  by nutritional supplement drinks Jaeri Lee1,†, Jung-Chul Park2,†, Ui-Won Jung2, Seong-Ho Choi2, Kyoo-Sung Cho2,  Yoo-Kyoung Park1,*, Chang-Sung Kim2,* 1Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University,  Yongin, Korea 2Department of Periodontology, Research Institute for Periodontal Regeneration, Yonsei University College  of Dentistry, Seoul, Korea Research Article J Periodontal Implant Sci 2014;44:109-117 http://dx.doi.org/10.5051/jpis.2014.44.3.109 Purpose:  The aim of this study was to determine the effects of nutritional supplements on  periodontal health and tooth mobility after surgery.",Non-OADS,/arxiv_data1/oa_pdf/a3/50/jpis-44-109.PMC4050227.pdf
It is well established that adequate host nutrition is important to maintain resistance to  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a3/50/jpis-44-109.PMC4050227.pdf
"Effects of nutritional supplement drinks on periodontal healing  http://dx.doi.org/10.5051/jpis.2014.44.3.109 www.jpis.org110periodontal disease [11,12], and has beneficial effects on the re - covery from periodontal treatment [13,14].",Non-OADS,/arxiv_data1/oa_pdf/a3/50/jpis-44-109.PMC4050227.pdf
"http://dx.doi.org/10.5051/jpis.2014.44.3.109 www.jpis.org111face is measured by the instrument, which calculates the Periotest  value to indicate tooth mobility [20].",Non-OADS,/arxiv_data1/oa_pdf/a3/50/jpis-44-109.PMC4050227.pdf
Effects of nutritional supplement drinks on periodontal healing  http://dx.doi.org/10.5051/jpis.2014.44.3.109 www.jpis.org112the participant flow chart.,Non-OADS,/arxiv_data1/oa_pdf/a3/50/jpis-44-109.PMC4050227.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.109 www.jpis.org113higher in the intervention group than in the control group.,Non-OADS,/arxiv_data1/oa_pdf/a3/50/jpis-44-109.PMC4050227.pdf
Effects of nutritional supplement drinks on periodontal healing  http://dx.doi.org/10.5051/jpis.2014.44.3.109 www.jpis.org114sis.,Non-OADS,/arxiv_data1/oa_pdf/a3/50/jpis-44-109.PMC4050227.pdf
"http://dx.doi.org/10.5051/jpis.2014.44.3.109 www.jpis.org115ing periodontal diseases, and improve the healing outcome after  periodontal therapy.",Non-OADS,/arxiv_data1/oa_pdf/a3/50/jpis-44-109.PMC4050227.pdf
Effects of nutritional supplement drinks on periodontal healing  http://dx.doi.org/10.5051/jpis.2014.44.3.109 www.jpis.org116ACKNOWLEDGEMENTS This research was supported by Basic Science Research Program  through the National Research Foundation of Korea (NRF) funded  by the Ministry of Education (No.,Non-OADS,/arxiv_data1/oa_pdf/a3/50/jpis-44-109.PMC4050227.pdf
ORCID Jaeri Lee http://orcid.org/0000-0002-6518-0917 Jung-Chul Park  http://orcid.org/0000-0002-2041-8047 Ui-Won Jung http://orcid.org/0000-0001-6371-4172 Seong-Ho Choi http://orcid.org/0000-0001-6704-6124 Kyoo-Sung Cho http://orcid.org/0000-0002-6777-5287 Yoo-Kyoung Park http://orcid.org/0000-0002-8536-0835 Chang-Sung Kim http://orcid.org/0000-0003-3902-1071 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a3/50/jpis-44-109.PMC4050227.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.109 www.jpis.org11728.,Non-OADS,/arxiv_data1/oa_pdf/a3/50/jpis-44-109.PMC4050227.pdf
"118 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Effects of scaling and root planing  with or without a local drug delivery  system on the gingival crevicular fluid  leptin level in chronic periodontitis  patients: a clinico-biochemical study Vinayak Venkoosa Meharwade1, Gunjiganur Vemanaradhya Gayathri2,*,  Dhoom Singh Mehta2  1Department of Periodontics, Sinhgad Dental College and Hospital, Pune, India 2Department of Periodontics, Bapuji Dental College and Hospital, Davangere, IndiaResearch Article J Periodontal Implant Sci 2014;44:118-125 http://dx.doi.org/10.5051/jpis.2014.44.3.118 Purpose:  The present split mouth study evaluates the effect of nonsurgical periodontal  treatment on the gingival crevicular fluid (GCF) leptin level in chronic periodontitis.",Non-OADS,/arxiv_data1/oa_pdf/f8/b9/jpis-44-118.PMC4050228.pdf
"Apart from this, GCF collection is a noninvasive  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/f8/b9/jpis-44-118.PMC4050228.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.118 www.jpis.org119and relatively simple procedure to perform [4].,Non-OADS,/arxiv_data1/oa_pdf/f8/b9/jpis-44-118.PMC4050228.pdf
"Nonsurgical therapy and GCF leptin level http://dx.doi.org/10.5051/jpis.2014.44.3.118 www.jpis.org120were immediately transported to the laboratory, where they were  stored at –80°C until the time of assay.",Non-OADS,/arxiv_data1/oa_pdf/f8/b9/jpis-44-118.PMC4050228.pdf
"http://dx.doi.org/10.5051/jpis.2014.44.3.118 www.jpis.org121wells, which developed a color in proportion to the amount of  leptin bound in the initial step.",OADS,/arxiv_data1/oa_pdf/f8/b9/jpis-44-118.PMC4050228.pdf
"Nonsurgical therapy and GCF leptin level http://dx.doi.org/10.5051/jpis.2014.44.3.118 www.jpis.org122The variation in the mean GCF leptin level at D0, D15, and D45  among the study groups was statistically not significant.",OADS,/arxiv_data1/oa_pdf/f8/b9/jpis-44-118.PMC4050228.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.118 www.jpis.org123which no correlation between the decreased levels of serum adi - ponectin and periodontitis was found [25].,Non-OADS,/arxiv_data1/oa_pdf/f8/b9/jpis-44-118.PMC4050228.pdf
"Nonsurgical therapy and GCF leptin level http://dx.doi.org/10.5051/jpis.2014.44.3.118 www.jpis.org124tween D15 and D45, GCF leptin levels of group III sites showed  significant variation ( P<0.05).",Non-OADS,/arxiv_data1/oa_pdf/f8/b9/jpis-44-118.PMC4050228.pdf
ORCID Vinayak Meharwade http://orcid.org/0000-0002-4806-3049 Gayathri Gunjiganur Vemanaradhya http://orcid.org/0000-0002-       7791-4113 Dhoom Singh Mehta http://orcid.org/0000-0003-2660-0429 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/b9/jpis-44-118.PMC4050228.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.118 www.jpis.org125JM.,OADS,/arxiv_data1/oa_pdf/f8/b9/jpis-44-118.PMC4050228.pdf
"126 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Evaluation of interleukin-1 β and 8 in  gutka chewers with periodontitis  among a rural Indian population Pulikottil Shaju Jacob1,*, Sonia Nath2, Ritu Prabha Patel3 1Department of Clinical Dentistry, International Medical University School of Dentistry, Kuala Lumpur,  Malaysia 2Department of Periodontology, Vananchal Dental College and Hospital, Garhwa, India 3Department of Periodontology, Chhattisgarh Dental College and Research Institute, Rajnandgaon, India Research Article J Periodontal Implant Sci 2014;44:126-133 http://dx.doi.org/10.5051/jpis.2014.44.3.126 Purpose:  Smokeless tobacco-based oral-use products like gutka are popular in India.",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/jpis-44-126.PMC4050229.pdf
"In contrast, smokeless tobacco products such as snuff, moist snuff,  and chewable forms like gutka, zarda, khaini, mawa, and pan are most commonly associat - ed with oral leukoplakia and oral submucous fibrosis [5], while periodontal effects include  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/jpis-44-126.PMC4050229.pdf
"http://dx.doi.org/10.5051/jpis.2014.44.3.126 www.jpis.org127localized gingival recession (RC) and clinical attachment loss [6,7].",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/jpis-44-126.PMC4050229.pdf
Cytokine levels in gutka chewers http://dx.doi.org/10.5051/jpis.2014.44.3.126 www.jpis.org128of ≥4 mm (not on the same tooth) or ≥2 interproximal sites with  probing depth (PD) of ≥5 mm (not on the same tooth) were pres - ent [23].,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/jpis-44-126.PMC4050229.pdf
"http://dx.doi.org/10.5051/jpis.2014.44.3.126 www.jpis.org129Clinical parameters (Table 2) The PI and GI values showed significant differences when com - pared group-wise ( P<0.001), but this difference was only present  when healthy subjects were compared to the periodontitis groups;  no significant difference was seen between the two periodontitis  groups.",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/jpis-44-126.PMC4050229.pdf
"Cytokine levels in gutka chewers http://dx.doi.org/10.5051/jpis.2014.44.3.126 www.jpis.org130and the buccal mucosa and is gently chewed or sucked over a pe - riod of time after which it is either spat out or swallowed [11,22,24].",Non-OADS,/arxiv_data1/oa_pdf/1f/f1/jpis-44-126.PMC4050229.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.126 www.jpis.org131ka chewers but did not reach statistical significance when com - pared with the nonchewing periodontitis subjects.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/jpis-44-126.PMC4050229.pdf
ORCID Pulikkotil Shaju Jacob http://orcid.org/0000-0001-5727-8255  Sonia Nath http://orcid.org/0000-0001-8714-7264 Ritu Prabha Patel http://orcid.org/0000-0002-3144-6561   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/jpis-44-126.PMC4050229.pdf
Available from: http://www.who.int/ tobacco/mpower/mpower_report_full_2008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/jpis-44-126.PMC4050229.pdf
Cytokine levels in gutka chewers http://dx.doi.org/10.5051/jpis.2014.44.3.126 www.jpis.org132cytokines in severe chronic periodontitis.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/jpis-44-126.PMC4050229.pdf
Available from:  http://mohfw.nic.in/WriteReadData/ l892s/1455618937GATS%20India.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/jpis-44-126.PMC4050229.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.126 www.jpis.org133Clin Periodontol 2003;30:145-53.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/jpis-44-126.PMC4050229.pdf
"134 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 A randomized clinical trial to evaluate  and compare the efficacy of triphala  mouthwash with 0.2% chlorhexidine  in hospitalized patients with  periodontal diseases Ritam S. Naiktari*, Pratima Gaonkar, Abhijit N. Gurav, Sujeet V. Khiste Department of Periodontology, Tatyasaheb Kore Dental College & Research Centre, Kolhapur, India Research Article J Periodontal Implant Sci 2014;44:134-140 http://dx.doi.org/10.5051/jpis.2014.44.3.134 Purpose:  Triphala is a combination of three medicinal plants, extensively used in Ayurveda  since ancient times.",Non-OADS,/arxiv_data1/oa_pdf/5c/de/jpis-44-134.PMC4050230.pdf
"However, CHX  has been reported to have a number of side effects like brown discoloration of teeth, salt  taste perturbation, oral mucosal erosions, and enhanced supragingival calculus formation,  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/5c/de/jpis-44-134.PMC4050230.pdf
"http://dx.doi.org/10.5051/jpis.2014.44.3.134 www.jpis.org135which limit its long-term use [3,12-14].",Non-OADS,/arxiv_data1/oa_pdf/5c/de/jpis-44-134.PMC4050230.pdf
"Efficacy of triphala mouthwash: RCT http://dx.doi.org/10.5051/jpis.2014.44.3.134 www.jpis.org136and analyzed with a statistical package, IBM SPSS ver.",Non-OADS,/arxiv_data1/oa_pdf/5c/de/jpis-44-134.PMC4050230.pdf
"http://dx.doi.org/10.5051/jpis.2014.44.3.134 www.jpis.org137Side effects if any: within group There were no side effects reported by patients in group A and  group C. However, patients from group B reported that there was  slightly altered taste sensation and burning sensation after rinsing  with CHX.",Non-OADS,/arxiv_data1/oa_pdf/5c/de/jpis-44-134.PMC4050230.pdf
Efficacy of triphala mouthwash: RCT http://dx.doi.org/10.5051/jpis.2014.44.3.134 www.jpis.org138toxins from the liver.,Non-OADS,/arxiv_data1/oa_pdf/5c/de/jpis-44-134.PMC4050230.pdf
"http://dx.doi.org/10.5051/jpis.2014.44.3.134 www.jpis.org139ease, every effort has to be taken for the prevention of its forma - tion and accumulation.",Non-OADS,/arxiv_data1/oa_pdf/5c/de/jpis-44-134.PMC4050230.pdf
ORCID  Ritam S. Naiktari http://orcid.org/0000-0002-0923-4829 Pratima Gaonkar http://orcid.org/0000-0002-9259-1914 Abhijit N. Gurav  http://orcid.org/0000-0002-1530-5160 Sujeet V. Khiste http://orcid.org/0000-0003-2718-1465 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/de/jpis-44-134.PMC4050230.pdf
Efficacy of triphala mouthwash: RCT http://dx.doi.org/10.5051/jpis.2014.44.3.134 www.jpis.org140antimicrobial activity of triphala Mashi-an Ayurvedic formula - tion.,Non-OADS,/arxiv_data1/oa_pdf/5c/de/jpis-44-134.PMC4050230.pdf
"141 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Receptor activator of nuclear factor  kappa-B gene polymorphisms in  Iranian periodontitis and   peri-implantitis patients Mahdi Kadkhodazadeh1, Zahra Baghani2,*, Ahmad Reza Ebadian3,  Zahra Kaghazchi2, Reza Amid1  1Department of Periodontics, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran,  Iran 2Department of Periodontics, School of Dentistry, International Branch, Shahid Beheshti University of  Medical Sciences, Tehran, Iran 3Private Practice, Mashhad, IranResearch Article J Periodontal Implant Sci 2014;44:141-146 http://dx.doi.org/10.5051/jpis.2014.44.3.141 Purpose:  Peri-implantitis and periodontitis are inflammatory and infectious diseases of im - plant and tooth-supporting tissues.",Non-OADS,/arxiv_data1/oa_pdf/2f/37/jpis-44-141.PMC4050231.pdf
Genetic differences are responsible for vari - This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2f/37/jpis-44-141.PMC4050231.pdf
RANK  gene polymorphisms in peri-implantitis http://dx.doi.org/10.5051/jpis.2014.44.3.141 www.jpis.org142ations in individual immune responses to periodontal pathogens [2].,Non-OADS,/arxiv_data1/oa_pdf/2f/37/jpis-44-141.PMC4050231.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.141 www.jpis.org143CAGGA rs35211496 AGTGCGCGCCGGGCCTGGGCGCCCAG[C/T]ACCCGTGTACGGGTTG GATGTGTGC IBM SPSS ver.,OADS,/arxiv_data1/oa_pdf/2f/37/jpis-44-141.PMC4050231.pdf
RANK  gene polymorphisms in peri-implantitis http://dx.doi.org/10.5051/jpis.2014.44.3.141 www.jpis.org144and genetic factors.,Non-OADS,/arxiv_data1/oa_pdf/2f/37/jpis-44-141.PMC4050231.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.141 www.jpis.org145pose that this issue be investigated in a larger sample of Iranian  patients and in different populations.,Non-OADS,/arxiv_data1/oa_pdf/2f/37/jpis-44-141.PMC4050231.pdf
ORCID Mahdi Kadkhodazadeh http://orcid.org/0000-0002-6131-2791 Zahra Baghani http://orcid.org/0000-0003-0847-7076 Ahmad Reza Ebadian http://orcid.org/0000-0002-6015-5966 Zahra Kaghazchi http://orcid.org/0000-0002-5815-0074 Reza Amid http://orcid.org/0000-0002-8053-3928  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/37/jpis-44-141.PMC4050231.pdf
RANK  gene polymorphisms in peri-implantitis http://dx.doi.org/10.5051/jpis.2014.44.3.141 www.jpis.org146with inflammatory cells.,Non-OADS,/arxiv_data1/oa_pdf/2f/37/jpis-44-141.PMC4050231.pdf
"147 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286 Anterior maxillary defect  reconstruction with a staged bilateral  rotated palatal graft Gyu-Un Jung1, Eun-Kyoung Pang1, Chang-Joo Park2,* 1Department of Periodontology, Ewha Womans University Graduate School of Medicine, Seoul, Korea 2Division of Oral and Maxillofacial Surgery, Department of Dentistry, Hanyang University College of    Medicine, Seoul, Korea Case Report J Periodontal Implant Sci 2014;44:147-155 http://dx.doi.org/10.5051/jpis.2014.44.3.147 Purpose:  In the anterior maxilla, hard and soft tissue augmentations are sometimes re - quired to meet esthetic and functional demands.",Non-OADS,/arxiv_data1/oa_pdf/64/a9/jpis-44-147.PMC4050232.pdf
This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/64/a9/jpis-44-147.PMC4050232.pdf
"Palatal rotated flap for anterior maxillary defect http://dx.doi.org/10.5051/jpis.2014.44.3.147 www.jpis.org148Various bone reconstruction techniques such as block grafts,  particulate grafts, ridge expansion techniques, guided bone regen - eration (GBR), and distraction osteogenesis have been used for this  purpose [6-12].",Non-OADS,/arxiv_data1/oa_pdf/64/a9/jpis-44-147.PMC4050232.pdf
"http://dx.doi.org/10.5051/jpis.2014.44.3.147 www.jpis.org149Pharm., Seoul, Korea) 3 times a day for 7 days along with 0.12%  chlorhexidine mouth wash.",Non-OADS,/arxiv_data1/oa_pdf/64/a9/jpis-44-147.PMC4050232.pdf
Palatal rotated flap for anterior maxillary defect http://dx.doi.org/10.5051/jpis.2014.44.3.147 www.jpis.org150with membrane removal 7 weeks after the stage 1 surgery.,Non-OADS,/arxiv_data1/oa_pdf/64/a9/jpis-44-147.PMC4050232.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.147 www.jpis.org151dure was completed after a 6-month healing period.,Non-OADS,/arxiv_data1/oa_pdf/64/a9/jpis-44-147.PMC4050232.pdf
Palatal rotated flap for anterior maxillary defect http://dx.doi.org/10.5051/jpis.2014.44.3.147 www.jpis.org152 A B Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/64/a9/jpis-44-147.PMC4050232.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.147 www.jpis.org153after the grafting procedure.,Non-OADS,/arxiv_data1/oa_pdf/64/a9/jpis-44-147.PMC4050232.pdf
Palatal rotated flap for anterior maxillary defect http://dx.doi.org/10.5051/jpis.2014.44.3.147 www.jpis.org154ported.,Non-OADS,/arxiv_data1/oa_pdf/64/a9/jpis-44-147.PMC4050232.pdf
ORCID Gyu-Un Jung http://orcid.org/0000-0001-5622-1126 Eun-Kyoung Pang http://orcid.org/0000-0002-2633-109X Chang-Joo Park http://orcid.org/0000-0002-6895-9854 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/64/a9/jpis-44-147.PMC4050232.pdf
http://dx.doi.org/10.5051/jpis.2014.44.3.147 www.jpis.org15531.,Non-OADS,/arxiv_data1/oa_pdf/64/a9/jpis-44-147.PMC4050232.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/19/bf/ncomms4945.PMC4050235.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Rozynek, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/19/bf/ncomms4945.PMC4050235.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4945 6 NATURE COMMUNICATIONS | 5:3945 | DOI: 10.1038/ncomms4945 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/19/bf/ncomms4945.PMC4050235.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Brain sparing in fetal mice LS Cahill et al 1088 Journal of Cerebral Blood Flow & Metabolism (2014), 1082 – 1088 &2014 ISCBFM",Non-OADS,/arxiv_data1/oa_pdf/0d/c7/jcbfm201462a.PMC4050255.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/68/84/ncomms4915.PMC4050256.pdf
Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Neuner J. et al.,Non-OADS,/arxiv_data1/oa_pdf/68/84/ncomms4915.PMC4050256.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4915 12 NATURE COMMUNICATIONS | 5:3915 | DOI: 10.1038/ncomms4915 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/68/84/ncomms4915.PMC4050256.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/ncomms4995.PMC4050257.pdf
"Reprints and permission information is available online at http://www.nature.com/ reprintsandpermissions/ How to cite this article: Kolodziej, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/9f/ce/ncomms4995.PMC4050257.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4995 12 NATURE COMMUNICATIONS | 5:3995 | DOI: 10.1038/ncomms4995 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/9f/ce/ncomms4995.PMC4050257.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/b2/e3/ncomms4891.PMC4050264.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Majeed, S. R. et al.",Non-OADS,/arxiv_data1/oa_pdf/b2/e3/ncomms4891.PMC4050264.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4891 14 NATURE COMMUNICATIONS | 5:3891 | DOI: 10.1038/ncomms4891 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/b2/e3/ncomms4891.PMC4050264.pdf
Gene and genome analyses.The open-reading frame (ORF) predictions and annotations for the assembled genomes and contigs were conducted using Migap (http://www.migap.org/index.php/en)64.,OADS,/arxiv_data1/oa_pdf/90/bd/ncomms4900.PMC4050266.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/90/bd/ncomms4900.PMC4050266.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Suzuki, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/90/bd/ncomms4900.PMC4050266.pdf
"To view a copy of this license, visit http://creativecommon-s.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4900 12 NATURE COMMUNICATIONS | 5:3900 | DOI: 10.1038/ncomms4900 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/90/bd/ncomms4900.PMC4050266.pdf
"Methods Water .We carried out ab initio MD simulations of water under pressure as a function of temperature in the Born-Oppenheimer approximation with the Qbox code (version 1.54.2, http://eslab.ucdavis.edu/software/qbox/)43.",Non-OADS,/arxiv_data1/oa_pdf/09/96/ncomms4919.PMC4050267.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/09/96/ncomms4919.PMC4050267.pdf
Reprints and permission information is available online at http://www.nature.com/ reprints/index.html.,Non-OADS,/arxiv_data1/oa_pdf/09/96/ncomms4919.PMC4050267.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4919 6 NATURE COMMUNICATIONS | 5:3919 | DOI: 10.1038/ncomms4919 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/09/96/ncomms4919.PMC4050267.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Jourdan, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/2d/da/ncomms4974.PMC4050270.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f3/27/ncomms4932.PMC4050274.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Katanosaka, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/f3/27/ncomms4932.PMC4050274.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4932 14 NATURE COMMUNICATIONS | 5:3932 | DOI: 10.1038/ncomms4932 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f3/27/ncomms4932.PMC4050274.pdf
"60, http://re.jrc.ec.europa.eu/ pvgis/download/download.htm), atmospheric corrections were already applied to account for spatial differences in, for example, average cloud cover, atmospheric300 200 100 0 –6 –4 –2 0 2 4 6 8 Chan ge in dra gonfly colour li ghtness (raw data)–6 –4 –2 0 2 4200 100 0 0.152 0.158 0.000 0.006 0.012 Means of 1,000 trees Means of 1,000 treesFrequency 68 –0.2 –0.1 0.0 0.1 Chan ge in dra gonfly colour li ghtness (P component) Chan ge in dra gonfly colour li ghtness (S component)Frequency Figure 3 | Shift in the mean colour value of dragonﬂy assemblages across Europe between 1988 and 2006.",Non-OADS,/arxiv_data1/oa_pdf/a3/db/ncomms4874.PMC4050276.pdf
"Data were taken from BioClim61, available at http://www.worldclim.org/current.",OADS,/arxiv_data1/oa_pdf/a3/db/ncomms4874.PMC4050276.pdf
"Data were taken from BioClim61, available at http://www.worldclim.org/current.",OADS,/arxiv_data1/oa_pdf/a3/db/ncomms4874.PMC4050276.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/a3/db/ncomms4874.PMC4050276.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zeuss, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/a3/db/ncomms4874.PMC4050276.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4874 ARTICLE NATURE COMMUNICATIONS | 5:3874 | DOI: 10.1038/ncomms4874 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/a3/db/ncomms4874.PMC4050276.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/nature communicationsNATURE COMMUNICATIONS | DOI: 10.1038/ncomms4835 ARTICLE NATURE COMMUNICATIONS | 5:3835 | DOI: 10.1038/ncomms4835 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.,Non-OADS,/arxiv_data1/oa_pdf/76/04/ncomms4835.PMC4050277.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Enrı´quez, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/76/04/ncomms4835.PMC4050277.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4835 12 NATURE COMMUNICATIONS | 5:3835 | DOI: 10.1038/ncomms4835 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/76/04/ncomms4835.PMC4050277.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/nature communications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/4e/98/ncomms4867.PMC4050278.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Meli, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/4e/98/ncomms4867.PMC4050278.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/d5/cc/ncomms5000.PMC4050279.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Poh, Y.-C. et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/cc/ncomms5000.PMC4050279.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5000 12 NATURE COMMUNICATIONS | 5:4000 | DOI: 10.1038/ncomms5000 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/d5/cc/ncomms5000.PMC4050279.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/81/main.PMC4050285.pdf
He achieved a complete remission but 17 months later developed acuteContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2014.04.001 2213-0489/ &2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/36/81/main.PMC4050285.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/81/main.PMC4050285.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/69/main.PMC4050286.pdf
Despite additionalContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2014.05.001 2213-0489/ &2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/69/main.PMC4050286.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/69/main.PMC4050286.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/66/main.PMC4050287.pdf
"Fluorescent in situ hybridization (FISH) studies did not show bcr/abl (breakpoint cluster region/Abelsen), PML/RARA (promye- locytic leukemia/retinoic acid receptor alpha), CBFB/MYH11 (core binding factor β/myosin heavy chain11), AML1/ETO (acute myeloid leukemia 1/eight-twenty one), ETV6/RUNX1 (ETS variant 6/Runt related transcription factor 1) translocation or MLL (mixed lineage leukemia) gene rearrangement.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2014.04.003 2213-0489/ &2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/df/66/main.PMC4050287.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/66/main.PMC4050287.pdf
〈http://cgap.nci.nih.gov.,Non-OADS,/arxiv_data1/oa_pdf/df/66/main.PMC4050287.pdf
http://dx.doi.org/10.1016/j.nicl.2014.05.016,OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1037/0033-2909.99.2.229  , 3515383  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1176/appi.ajp.2009.09010043  ,  19917597  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1176/appi.ajp.2013.12070880  , 24030612  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.org/10.1098/rstb.2007.2088  .,Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1006/nimg.1997.0291  , 9344826  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1016/S1053-  8119(03)00058-  2 ,  12781739  .",OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1038/npp.2009.129  ,  19812543  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1016/S0165-1781(03)   00136-7  , 12914892  .",OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1016/j.neuroimage.2004.01.041  , 15193596  .",OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"Neuropsychology  18, 485– 503. http://dx.doi.org/10.1037/0894-4105.18.3.485  , 15291727  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.org/10.1098/rstb.2006.,OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1007/s10802-  006- 9096- x , 17243015  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1038/npp.2009.110  , 19710631  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.04.,OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1176/appi.ajp.2007.07071145  ,  18281412  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1007/s10802-  007- 9167- 7 ,  17701339  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1016/j.jaac.2010.07.009  ,  20855051  .",OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1037/0894-4105.16.1.102  , 11853351  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1586/ern.12.109  ,  23082740  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/   10.1016/j.conb.2007.02.008  , 17350248  .",OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1002/hbm.20706  , 19086020  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1007/   s00213- 012- 2893- 8 , 23086020  .",Non-OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1002/(SICI)1097-4679(199901)55:1  < 117::  AID- JCLP12 > 3.0.CO;2-  A , 10100838  .",OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
"http://dx.doi.org/10.1016/j.psychres.2008.05.006  ,  19564050  .",OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c2/92/main.PMC4050315.pdf
http://dx.doi.org/10.1016/j.nicl.2014.05.011,OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1006/nimg.2000.0582  , 10860804  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/   10.1037/0033-295X.108.3.624  , 11488380  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/   10.1016/j.tics.2004.10.003  , 15556023  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1016/j.drugalcdep.2011.08.007  , 21885214  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1016/j.jneumeth.2009.12.009  , 20035787  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1016/j.clinph.2004.11.025  ,  15996897  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.,OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/   10.1016/S0001-  6918(99)00008-  6 , 10344188  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
http://dx.doi.org/10.1027//0269-8803.16.3.167  .,Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
http://dx.doi.org/10.1111/j.1460-9568.2006.,Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
http://dx.doi.org/10.1111/j.1469-8986.,Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
http://dx.doi.org/10.1038/nrn3119  .,Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1007/s00429-  012- 0483- 5 ,  23179865  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"Electroencephalography  and Clinical Neurophysiology  82, 477– 82. http://dx.doi.org/10.1016/0013-  4694(92)90054-  L, 1375556  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1046/j.1469-8986.2003.00127.x  ,  14692996  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1002/mrm.1910340305  , 7500867  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1016/S0028-  3932(99)00106-  2 , 10689046  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1371/journal.pone.0018898  , 21526125  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1016/S1053-  8119(03)00244-  1 ,  12880835  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1136/jnnp.2006.095869  ,  17088334  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.3758/CABN.3.1.17  , 12822595  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1162/   jocn a 00166 , 22098260  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1016/j.pscychresns.2012.01.001  , 22841343  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1037/1040-3590.14.2.150  , 12056077  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1097/   00004691-  199210000-  00002 , 1464675  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1016/0006-  3223(93)90097-  W ,  8329490  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1016/j.clinph.2004.01.028  , 15203056  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1080/10874200802502144  ,  19830263  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1016/S0168-  5597(98)00021-  5 , 9714383  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1016/   S0031- 9384(02)00930-  7 , 12526986  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/   10.1016/S0028-  3932(02)00297-  X , 12667546  .",OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/   10.1111/j.1469-8986.2004.00205.x  , 15318880  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
"http://dx.doi.org/10.1037/0033-295X.111.4.931  , 15482068  .",Non-OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
http://dx.doi.org/10.1016/j.bandc.2009.08.,OADS,/arxiv_data1/oa_pdf/a1/59/main.PMC4050316.pdf
http://dx.doi.org/10.1016/j.nicl.2014.05.010,OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1542/peds.113.4.846  , 15060237  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1111/j.1469-8749.2001.tb00179.x  ,  11263683  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/   10.1016/j.neuropsychologia.2008.03.019  , 18439631  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1016/j.jns.2009.02.313  , 19264326  .",OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1371/journal.pone.0077475  , 24130887  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1016/j.pscychresns.2012.04.017  , 23149028  .",OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.org/10.1006/nimg.,OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1016/j.neuroimage.2006.01.021  ,  16530430  .",OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1006/nimg.1998.0396  , 9931269  .",OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1093/   arclin/16.2.183  , 14590186  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1542/peds.2006-1037  , 17088402  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1016/S0140-  6736(73)91092-  1 ,  4127281  .",OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1111/j.1530-0277.2009.01097.x  ,  19930234  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.2307/3109764  , 9629645  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1002/hbm.20747  ,  19278010  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1007/s11065-  011- 9167- 9 , 21503685  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1016/j.alcohol.2009.08.005  , 20036488  .",OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1111/j.1530-0277.1996.tb01951.x  , 8892532  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.2105/AJPH.2003.037093  ,  15933241  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1162/0898929041920441  ,  15453975  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1126/science.283.5409.1908  , 10082463  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.org/10.1212/01.wnl.,Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0054-11.2011  , 21562281  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1016/j.mri.2010.01.003  ,",OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1007/   s11065- 011- 9166- x , 21499711  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1111/j.1530-0277.1995.tb01600.x  ,  8561290  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1002/(SICI)1096-9926(199711)56:5%3C317::   AID- TERA5%3E3.3.CO;2-  T] , 9451756  .",OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1002/hbm.20149  ,  15858815  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1006/cogp.1997.0658  , 9212720  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.org/10.1126/science.283.5408.,Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.5067-07.2008  , 18256251  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1093/cercor/   bhm039 , 17443018  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1212/WNL.57.2.235  , 11468307  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1093/cercor/12.8.856  , 12122034  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1001/jama.1991.03460150065025  , 2008025  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1097/   00004703-  200408000-  00002 , 15308923  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1016/   j.biopsych.2004.03.016  , 15231439  .",OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1016/   S0074- 7742(05)67009-  2 , 16291026  .",OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.5004-12.2013  , 23761905  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1016/j.neuropsychologia.2004.04.006  ,  15193947  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.,OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1055/   s- 0032- 1306382  , 22422203  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1007/s11065-  011- 9162- 1 , 21347880  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
"http://dx.doi.org/10.1111/j.1530-0277.2011.01679.x  ,  22150665  .",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/main.PMC4050317.pdf
http://dx.doi.org/10.1016/j.rinim.2014.05.001,OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1159/000060527  , 11569409  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1007/   s00281- 010- 0204- 1 , 20424843  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.2337/   db08-0767  , 18776136  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1038/366072a0  , 8232539  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1126/science.7761837  ,  7761837  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
http://dx.doi.org/10.4049/jimmunol.,Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.2337/diab.44.10.1186  ,  7556956  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.2174/138920208785133253  , 19471607  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1084/jem.180.4.1553  , 7931087  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.2337/db09-0648  , 19833887  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1042/BST0360321  , 18481950  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1038/nature06757  , 18344982  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1371/journal.pone.0006250  ,  19609442  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1038/nature08454  ,  19741703  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1371/journal.pone.0046941  , 23071669  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1093/nar/gki475  , 15980575  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1093/emboj/20.9.2140  , 11331580  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1128/JVI.01804-12  , 23077300  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1038/ni.2293  , 22544392  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1016/   j.clim.2008.07.028  , 18801706  .",OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1186/gb-  2007- 8- 1- r12 , 17239257  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1038/nature09386  , 20827270  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1016/j.jaut.2010.03.001  , 20356713  .",OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1016/j.jaut.2007.01.002  ,  17320348  .",OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.4049/jimmunol.1103598  , 22450809  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"Annual Review of Immunology  2001;19:623– 55. http://dx.doi.org/10.1146/annurev.immunol.19.1.623  , 11244049  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1038/ni1538  , 18059273  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"http://dx.doi.org/10.1038/ni0108-9  , 18087248  .",Non-OADS,/arxiv_data1/oa_pdf/45/cd/main.PMC4050318.pdf
"2001;139(3):374-9, http://dx.doi.org/10.1067/mpd.2001.117077.",Non-OADS,/arxiv_data1/oa_pdf/e6/f0/cln-69-06-393.PMC4050319.pdf
"2010;95(3):F194-200, http://dx.doi.org/10.1136/adc.2009.",Non-OADS,/arxiv_data1/oa_pdf/e6/f0/cln-69-06-393.PMC4050319.pdf
"2002;110(3):517-22, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e6/f0/cln-69-06-393.PMC4050319.pdf
"2008;97(10):1370-5, http://dx.doi.org/10.1111/j.1651-2227.2008.00943.x.",Non-OADS,/arxiv_data1/oa_pdf/e6/f0/cln-69-06-393.PMC4050319.pdf
"Pro Fono 2009;21(4):315-9, http://dx.doi.org/10.1590/S0104-56872009000400009.",Non-OADS,/arxiv_data1/oa_pdf/e6/f0/cln-69-06-393.PMC4050319.pdf
"2008;41(10):904-7, http://dx.doi.org/10.1590/S0100-879X2008001000012.",Non-OADS,/arxiv_data1/oa_pdf/e6/f0/cln-69-06-393.PMC4050319.pdf
"2008;97(1):21-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e6/f0/cln-69-06-393.PMC4050319.pdf
"1996;87(2):163-8, http://dx.doi.org/10.1016/0029-7844(95)00386-X.",Non-OADS,/arxiv_data1/oa_pdf/e6/f0/cln-69-06-393.PMC4050319.pdf
"1998;12(2):193-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2009;73(2):311-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2007;21(2):152-60, http://dx.doi.org/10.1007/s00464-006-0250-x.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2008;294(3):R842-50, http://dx.doi.org/10.1152/ajpregu.00691.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"1983;197(2):183-7, http://dx.doi.org/10.1097/00000658-198302000-00010.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"1982;196(5):594-7, http://dx.doi.org/10.1097/00000658-198211000-00015.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"1998;79(2):109-14, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2000;36(1):29-34, http://dx.doi.org/10.1053/ajkd.2000.8237.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2004;18(1):31-5, http://dx.doi.org/10.1002/jcla.20005.Table 2 - Pearson’s correlation between Cys C levels (mg.L-1), creatinine values (mg.dL-1), and the GFR (mL.min-1) at three different studied time points (average ¡standard deviation).",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2002;35:63-99, http://dx.doi.org/10.1016/S0065-2423(01) 35015-1.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2005;38(1):1-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2004;64(1):25-30, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"1976;16:31-41, http://dx.doi.org/10.1159/000180580.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"1994;8(4):349-52, http://dx.doi.org/10.1089/end.1994.8.349.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2003;18(10):2024-31, http://dx.doi.org/10.1093/ndt/gfg349.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2004;256(6):510-8, http://dx.doi.org/10.1111/j.1365-2796.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2007;156:203-12, http://dx.doi.org/10.1159/000102085.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2008;36(4 Suppl):S152-8, http://dx.doi.org/10.1097/CCM.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2000;36(1):29-34, http://dx.doi.org/10.1053/ajkd.2000.8237.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2003;18(10):2024-31, http://dx.doi.org/10.1093/ndt/gfg349.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2002;40(2):221-6, http://dx.doi.org/10.1053/ajkd.2002.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2004;65(4):1416-21, http://dx.doi.org/10.1111/j.1523-1755.2004.00517.x.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"2009;75(6):652-60, http://dx.doi.org/10.1038/ki.2008.638.CLINICS 2014;69(6):378-383 Cystatin C for assessment of renal function Lima RM et al.",Non-OADS,/arxiv_data1/oa_pdf/3b/82/cln-69-06-378.PMC4050320.pdf
"1998;93(2):165-76, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2001;142(12):5050-5, http://dx.doi.org/10.1210/endo.142.12.8536.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2004;95(11): 1046-57, http://dx.doi.org/10.1161/01.RES.0000149165.99974.12.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2005;36(1-2):59-67, http://dx.doi.org/10.1007/s10735-004-3839-1.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2011;17(10):1231-4, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"1999;96(7):3540-5, http://dx.doi.org/ 10.1073/pnas.96.7.3540.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2007;9 Suppl 1:S1, http://dx.doi.org/10.1186/ ar2165.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2001;79(5-6):243-53, http://dx.doi.org/10.1007/s001090100226.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2003;423(6937):337-42, http://dx.doi.org/10.1038/ nature01658.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2004;292(4):490-5, http://dx.doi.org/10.1001/jama.292.4.490.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2000;289(5484):1508-14, http://dx.doi.org/10.1126/science.289.5484.1508.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2001;(382):6-12, http://dx.doi.org/10.1097/00003086-200101000- 00003.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2000;88(12 Suppl):2961-78, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"1973;11(4):269-80, http://dx.doi.org/10.1007/BF02547227.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2003;33(2):216-28, http://dx.doi.org/10.1016/ S8756-3282(03)00223-0.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2004;9 Suppl 4:3-13, http://dx.doi.org/10.1634/theoncologist.9-90004-3.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2002;2(6):571-7, http://dx.doi.org/10.2174/1566524023362104.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2000;302(3):353-63, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"1989;83(6):1930-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2005;26(34):6941-9, http://dx.doi.org/10.1016/j.biomaterials.2005.04.059.",OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2003;72(2):143-50, http://dx.doi.org/10.1007/ s00223-001-2066-y.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2002;71(3):257-68, http://dx.doi.org/10.1023/A:1014418017382.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"1993;91(5):2004-11, http://dx.doi.org/10.1172/JCI116422.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2000;136(5):344-54, http://dx.doi.org/10.1067/mlc.2000.109757.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2002;291(3):680-6, http://dx.doi.org/10.1006/ bbrc.2002.6510.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"2004;25(18):4105-15, http://dx.doi.org/10.1016/j.biomaterials.2003.11.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"1998;22(5):455-61, http://dx.doi.org/10.1016/S8756-3282(98) 00033-7.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
"1998;68(2):186-94, http://dx.doi.org/10.1002/(SICI)1097-4644 (19980201)68:2 ,186::AID-JCB5 .3.0.CO;2-R. 41.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/cln-69-06-438.PMC4050321.pdf
